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Summary 
Membrane trafficking between organelles is fundamental to the existence of eukaryotic cells. 
A multitude of proteins is involved in membrane trafficking, acting as building blocks for 
transport carriers, regulators of transport, and targeting and fusion factors. One important 
group of regulators are the Rab GTPases. They serve as multifaceted organizers of almost 
all membrane trafficking related processes in eukaryotic cells. In their active state, Rab pro-
teins bind to effectors to mediate their function. One of these effector proteins is Rabaptin5, 
an early endosome protein with binding sites for Rab4, Rab5, the Rab5 GDP/GTP exchange 
factor Rabex5, as well as for the clathrin coat adaptor AP1. Rabaptin5 is considered to be 
the prototype of a Rab effector mediating a positive feedback loop by binding to active Rab5 
and bringing along Rabex5, which activates further Rab5, thus maintaining endosomal fusion 
activity. Via the separate Rab4 interaction domain, Rabaptin5 has been proposed to function 
as a molecular linker between Rab5 and Rab4 to coordinate endocytic and recycling traffic. 
In the present study, we analysed the function of Rabaptin5 in more detail by mutagenesis of 
the different interaction domains or motifs and expression of the mutant proteins in HeLa 
cells. We identified two independent Rab4 binding domains in the N-terminal half of the pro-
tein and two cooperating sequences binding to Rab5a. Deletion of the Rab4 and Rabex5 
binding domains, respectively, abolished endosome recruitment of Rabaptin5 mutants. Inac-
tivation of Rab4a and Rabex5 by siRNA-mediated silencing, respectively, completely pre-
vented membrane binding of wildtype Rabaptin5, confirming the requirement for Rab4a and 
Rabex5 and excluding indirect structural effects of the deletions. Interestingly, deletion of 
either one of the two Rab5 binding domains showed no effect on endosome recruitment, but 
induced giant endosomes positive for markers of early endosomes like Rab4a, Rab5a, and 
transferrin, but also for the late endosomal markers Rab7a and the ESCRT component 
CHMP2B, suggesting the formation of early/late endosomal chimeras. The complete disrup-
tion of the Rabaptin5/Rab5a interaction produced giant endosomes with only late endosomal 
properties.  
Our results clearly contradict the widely accepted feedback model, in which Rab5 controls its 
own activity. They rather indicate that Rabaptin5 is recruited to endosomes by Rab4a-GTP 
and Rabex5, which locally activates Rab5a by nucleotide exchange. At the same time, acti-
vated Rab5a appears to inhibit or moderate Rabaptin5 driven endosome maturation, since 
deletion of the Rab5 binding domains on Rabaptin5 induces a premature maturation process. 
The mechanism of Rabaptin5 driven endosome maturation remains to be clarified by further 
investigation. 
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Introduction 
1. Intracellular transport 
Membrane traffic in higher eukaryotes is a fundamental function. Every cell takes up external 
molecules, communicates with the world around it and quickly responds to changes in its 
environment. To fulfil these tasks, cells continually adjust the composition of their plasma 
membrane in rapid response to need. An extensive internal membrane system is used to add 
and remove cell-surface proteins integrated in the plasma membrane. Through the process 
of exocytosis, the secretory pathway delivers newly synthesized proteins, carbohydrates and 
lipids to the plasma membrane and the cell exterior. Through endocytosis, the opposite pro-
cess, plasma membrane lipids, integral proteins and extracellular fluid is internalized and can 
be recycled or sent for degradation. Great progress has been made in the last decades to 
understand the basic mechanisms of protein transport, although a lot of the details of the 
different pathways are still missing. There are two major processes to transfer cargo from 
one organelle to another, called vesicular transport and organelle maturation. 
 
1.1. Vesicular transport 
Of the different cargo transfers between organelles, the vesicular transport is the best stud-
ied. The different types of vesicles are classified according to their proteins building the coat, 
the best studied of which are COPI, COPII, and clathrin coated vesicles. The vesicular 
transport hypothesis states that cargo is selectively incorporated into vesicles and transport-
ed from a donor compartment to a specific acceptor compartment. Specific coat proteins 
recognize cargo proteins and recruit other proteins to deform the membrane leading in pinch-
ing off a vesicle. The vesicle is actively transported along cytoskeletal filaments to the accep-
tor compartment where fusion occurs (Fig. 1) (Bonifacino and Glick, 2004; Spang, 2008) 
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Fig. 1. Steps of vesicle budding and fusion 
Vesicluar transport occurs in the following steps: coat initiation (1), budding (2) and scission (3), followed 
by uncoating (4), tethering (5), docking (6) and fusion (7) (Bonifacino and Glick, 2004) 
1.1.1. Clathrin coated vesicles 
Clathrin coated vesicles (CCVs) are the best characterized transport carriers and the first to 
be discovered (Pearse, 1976). They form at the plasma membrane, TGN and endosomes 
and have a large variety of associated proteins. The main component of CCVs is clathrin 
itself, which forms a mechanical scaffold on the vesicle surface (Edeling et al., 2006). The 
formation of these vesicles is a complex process and requires a regulated interplay between 
clathrin, its adaptors, cargo proteins and accessory factors.  
 
 Clathrin 1.1.1.1.
Clathrin monomers assemble into triskelia, which form a lattice around the central membrane 
vesicle. Each clathrin protein consists of three trimerized heavy chains (CHCs) and three 
clathrin light chains (CLCs) (Ungewickell and Branton, 1981). The heavy chain can be subdi-
vided into a C-terminal proximal domain at the trimerization zone, a middle domain forming a 
typical knee and a N-terminal globular domain (Fig. 2), which provide the structural backbone 
of the clathrin lattice. The light chains bind primarily to the proximal leg portion of the heavy 
chain with some interaction near the trimerization domain and they are thought to regulate 
the formation and disassembly of the clathrin lattice by changing their conformation to either 
stabilize or destabilize the clathrin cage (Brodsky, 2012). 
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Fig. 2. Structure of clathrin heavy chain 
A representation of a clathrin triskelion, which highlights the various domains using different colours. A 
single clathrin heavy chain is subdivided into the C-terminal proximal domain (red), the middle domain 
forming the knee (blue and grey) and the N-terminal globular domain (green) (Brodsky, 2012). 
 
Although purified clathrin triskelia can spontaneously assemble into cages at low pH (Keen et 
al., 1979), adaptor proteins are necessary to form a clathrin coated vesicle in vivo. These 
adaptors bind to the N-terminal domain of clathrin. The first identified clathrin binding motive 
was the clathrin binding box (Dell'Angelica et al., 1998), a short consensus sequence of 
LΦXΦ[DE] (Φ is a bulky hydrophobic amino acid, X is a polar amino acid). Sequence analy-
sis of different clathrin binding proteins revealed additional binding motifs like DLL (Morgan et 
al., 2000) or the W box motif (Miele et al., 2004).  
 
 ARF proteins 1.1.1.2.
ADP ribosylation factors (ARFs) are a family of small GTPases that regulate membrane traf-
fic and organelle structure in eukaryotic cells. The function of ARF requires a switch between 
GDP- and GTP-bound forms. Hydrolysis of bound GTP is mediated by GTPase activating 
proteins (GAPs), whereas the exchange of GDP for tri-phosphate nucleotide is mediated by 
guanine nucleotide exchange factors (GEFs). The GTP-bound ARF undergoes a conforma-
tional change, leading to an exposure of a myrostoyl tail, which anchors the protein in the 
membrane. There, the ARFs generate binding sites for adaptor proteins. There are six 
mammalian ARF proteins named ARF1 to ARF6 (D'souza-Schorey and Chavrier, 2006).  
In many clathrin mediated transport pathways in the cell, ARF proteins are the first recruiters 
of adaptor and coat proteins as well as lipid-modifying enzymes. ARF1 is required for the 
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recruitment of the adaptor proteins AP1, AP3, AP4 and GGAs to the TGN (Boehm et al., 
2001; Dell'Angelica et al., 2000; Stamnes and Rothman, 1993), but is also involved in clath-
rin assembly at endosomes (Pagano et al., 2004; van Dam et al., 2002). At the Golgi, ARF1, 
3, 4 and 5 are all present and seem to have redundant functions since RNAi knockdown of 
the individual ARFs showed no effect on Golgi function (Volpicelli-Daley et al., 2005). ARF6 
is found on the plasma membrane and is implicated in regulation of endosomal trafficking 
and the structural organization of the cell surface (D'Souza-Schorey et al., 1995). It is in-
volved in clathrin independent endocytosis (Donaldson and Jackson, 2011) and thought to 
regulate clathrin mediated endocytosis (Poupart et al., 2007), although this still is highly de-
bated and not clear. 
 Adaptor proteins 1.1.1.3.
Adaptors represent a diverse group of proteins recognizing different classes of cargo recep-
tor. The best characterized are a family of closely related proteins called the adaptor proteins 
(APs) comprising AP1, AP2, AP3, AP4 and AP5. Each of these five classes are localized to 
different intracellular compartments and vary in their receptor specificity (Hirst et al., 2013). 
Each AP complex is composed of two large subunits (∼100kDa) called adaptins (a β-class 
adaptin, and one of either an α-,γ-,δ-,ε- or ζ-adaptin), a medium µ-subunit (∼50kDa) and a 
small σ-subunit (∼20kDa). The two large subunits can be subdivided into a C-terminal ap-
pendage domain connected to the N-terminal core domain via an unstructured flexible linker 
sequence (Kirchhausen, 1999). Adaptor complexes are organized in a typical structure with a 
core consisting of the small and medium subunit and the N-terminal trunk domains of the 
large subunits. All five APs bind directly to cytosolic sorting signals in transmembrane cargo 
proteins and have different subcellular localization. Whereas AP1 and AP2 are components 
of clathrin vesicles, AP4 and AP5 seem to act independently of clathrin (Hirst et al., 1999; 
2011). In HeLa cells, AP2 together with AP1 and AP3 are the most abundant, whereas AP4 
and AP5 are 1-2 order of magnitude less frequent (Fig. 3) (Hirst et al., 2013). 
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Fig. 3. AP complexes 
Schematic representation of the members of the heterotetrameric adaptor protein complexes and a 
summary of their properties. The colours represent the homology among the corresponding subunits 
(Canagarajah et al., 2013). 
 
AP1 
AP1 consists of two isoforms, which only differ in their µ1-subunit (Ohno et al., 1999). AP1A 
is ubiquitously expressed and involved in the assembly of clathrin coated vesicles at the TGN 
and endosomes (Traub et al., 1993), while AP1B is only found in polarized cells (Ohno et al., 
1999), where it mediates basolateral cargo sorting in epithelial cells (Fölsch et al., 1999). 
AP1A was believed to be responsible for anterograde transport from the TGN to endosomes 
(Doray et al., 2002). In addition, AP1A was shown to function at early endosomes where it is 
important for the recycling of cargo to the plasma membrane (Pagano et al., 2004). Other 
studies using cells derived from µ1A knockout mice show an involvement of AP1A in retro-
grade transport of cargo from endosomes to the TGN (Meyer et al., 2000).  
AP2 
AP2 is the best characterized adaptor complex and mediates the formation of CCVs from the 
plasma membrane for endocytosis (Owen et al., 2004). Knockout of AP2 is embryonically 
lethal showing its critical role in cell homeostasis (Mitsunari et al., 2005).  
AP2 interacts with clathrin through the clathrin box motif in the β2 hinge (Haar et al., 2000) 
and through interactions with the appendage domains (Owen et al., 2000). The appendage 
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domains are also responsible for the recruitment of a large number of accessory and regula-
tory proteins. The trunk of the α-subunit was shown to bind phosphoinositol-4,5-
bisphosphate (PI(4,5)P2) and phosphoinositol-3,4,5-triphosphate (PI(3,4,5)P3) (Gaidarov et 
al., 1996), which is responsible for the targeting of AP2 to the plasma membrane (Gaidarov 
and Keen, 1999). Membrane recruitment of AP2 is favoured by the binding to cargo sorting 
signals. The medium µ-subunit recognizes tyrosine-based and dileucine sorting signals in the 
cargo receptors. The phosphorylation of a threonine residue in the µ-subunit by its kinase 
AAK1 induces a conformational change that exposes the binding sites. Its open conformation 
is further stabilized by binding of µ2 to PI(4,5)P2 allowing simultaneous interaction with sorting 
signals and the lipid bilayer (Olusanya et al., 2001; Ricotta et al., 2002). 
AP3 
AP3 was identified in mammals on the basis of structural homology with AP1 and AP2 (Pe-
vsner et al., 1994). Two isoforms of AP3 exist: AP3A is ubiquitously expressed, while AP3B 
is found in neuroendocrine cells where it is involved in the biogenesis of synaptic vesicles 
from endosomes (Nakatsu and Ohno, 2003).  
Immunofluorescence and electron microscopy localized AP3A on the TGN and endosomes 
(Dell'Angelica et al., 1997). It is believed that AP3A traffics cargo from the TGN or early en-
dosomes to late endosomes or lysosomes (Nakatsu and Ohno, 2003). Localization of AP3A 
to its target membrane is highly dependent on ARF1, since ARF1 mutants locked in their 
GDP-bound form prevent binding of AP3 to organelles (Ooi et al., 1998). The interaction be-
tween AP3A and clathrin is highly debated. Studies showed that clathrin was not involved in 
AP3-containing vesicles and AP3 may use another scaffolding protein (Hirst and Robinson, 
1998). Another group, on the other hand, could show that the β3-subunit can interact with 
clathrin and also showed a colocalization with clathrin on endosomes (Dell'Angelica et al., 
1998). 
AP4 
AP4 is ubiquitously expressed in human tissue (Dell'Angelica et al., 1999) and even though it 
has a low abundance compared to the other adaptor proteins in the cell, AP4 seems to play 
an important role, since mutations in humans lead to severe neurological symptoms (Hirst et 
al., 2013). According to immunofluorescence microscopy AP4 is mainly located at the TGN 
colocalizing with TGN46 (Hirst et al., 1999). It is proposed that AP4 mediates anterograde 
trafficking between the TGN and the endosomes, since a study could show that a depletion 
of AP4 resulted in the redistribution of the amyloid precursor protein APP from endosomes to 
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the TGN (Burgos et al., 2010). Alternatively AP4 might be involved in the direct transport 
between the TGN and the plasma membrane (Simmen et al., 2002). 
Compared to the β-subunits of the other AP complexes, no clathrin binding motifs seem to be 
present on the β4-subunit. Consistent with this observation is that AP4 does not colocalize 
with clathrin and is not detectable in clathrin coated vesicles purified from pig brain (Hirst et 
al., 1999). Like AP1 and AP3, AP4 is targeted to the TGN by ARF1 because treatment of 
cells with brefeldin A disrupted the signal at the TGN (Boehm et al., 2001). 
AP5 
AP5 was only discovered in 2011, hence relatively little is known about its function (Hirst et 
al., 2011). In cells expressing GFP-tagged AP5, a punctate staining was observed that was 
concentrated in the perinuclear region and colocalizing with late endosomal/lysosomal mark-
ers (Hirst et al., 2011). 
Taking into account the low level of sequence similarity in the hinge and appendage regions 
of the ζ- and β5-subunits relative to the other large adaptins, AP5 does not associate with 
clathrin. During the discovery of AP5, SPG11 and SPG15 were co-immunoprecipitated. 
SPG15 harbours a FYVE domain that can bind to the endosomal phosphoinositide-3-
phosphate (PI(3)P). SPG11, on the other hand, shares salient features of domain organiza-
tion with clathrin heavy chain implying a role of SPG11 as a membrane scaffold (Hirst et al., 
2013). 
 
 GGAs 1.1.1.4.
Another family of clathrin adaptor proteins are the Golgi-localizing, γ-adaptin ear homology 
domain, ARF-binding proteins (GGA). There are three GGAs in mammals, GGA1, GGA2 and 
GGA3, which are monomeric and ubiquitously expressed. They are organized into four dis-
tinct domains: a VHS domain (found in Vps27, Hrs and Stam), a GAT domain (found in 
GGAs and TOM1), a hinge domain rich in prolines and serines, and a GAE domain (similar 
to the γ-adaptin ear domain) (Fig. 4) (Nakayama and Wakatsuki, 2003). 
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Fig. 4. Domain organization of GGAs and AP1 
The structure of GGAs is similar to the γ1-subunit of AP1. The sequences and proteins that bind to each 
domain are indicated with arrows. GGAs are recruited to membranes via the interaction with ARF in the 
GAT domain. The VHS domain is responsible for cargo recognition, the hinge region for clathrin recruit-
ment and the GAE domain for interaction with accessory proteins (Nakayama and Wakatsuki, 2003). 
 
VHS domains of mammalian GGAs recognize the acidic amino acid cluster-dileucine (ACLL) 
sequences within the cytoplasmic domains of transmembrane proteins found in the TGN 
(Puertollano et al., 2001). Through interaction with activated ARF, the GAT domain is re-
sponsible for targeting of GGAs onto TGN membranes. However it is unlikely that the specif-
ic TGN association of GGAs is determined solely by their interaction with ARF (Takatsu et 
al., 2002). The hinge region binds clathrin via type I clathrin-binding motifs (Dell'Angelica, 
2001). The GAE domains of GGAs and the ear domain of γ-adaptin have been shown to 
share several binding partners. These accessory proteins include Rabaptin5 (Mattera et al., 
2003), γ-synergin (Hirst et al., 2000), epsinR (Hirst et al., 2003) and enthoprotin (Wasiak et 
al., 2002). 
GGAs are involved in the packaging of the mannose-6-phosphate receptor (M6PR) and its 
ligands into clathrin coated vesicles at the TGN to deliver them to early or late endosomes. 
Coated buds and vesicles containing GGAs together with clathrin, AP1 and M6PRs have 
been observed at the TGN (Doray et al., 2002; Puertollano et al., 2001) but they were not 
enriched in purified clathrin coated vesicles (Hirst et al., 2000). A recent study proposes that 
GGAs act together with AP1 to transport hydrolase-receptor complexes in the anterograde 
direction, from the TGN to endosomal compartments, since purified CCVs from AP1 
knocksideways cells were strongly depleted from GGA2 (Hirst et al., 2012). 
Introduction   
   
 
 
15 
In addition, GGAs have an ubiquitin binding site on the GAT domain. They are proposed to 
play a role in the sorting of ubiquitinated proteins towards lysosomal degradation by seques-
tering these proteins to sites of clathrin coated vesicle formation (Pelham, 2004). 
 
1.1.2. Clathrin mediated endocytosis 
Clathrin mediated endocytosis involves the uptake of transport receptors with their cargo 
molecules from the plasma membrane to endosomes. Formation of CCVs can be generally 
divided into 5 stages: initiation, cargo selection, coat assembly, scission and uncoating 
(McMahon and Boucrot, 2011). 
Initiation/Nucleation 
Clathrin coated vesicle formation starts with the generation of a membrane invagination 
called a coated pit. Which proteins are responsible for the initiation step is highly debated. 
One study could show with single molecule imaging that endocytic sites begin with the simul-
taneous plasma membrane binding of two AP2 adaptors and one clathrin triskelion (Cocucci 
et al., 2012). Another study, however, implies that AP2 may not be required at the earliest 
stages of endocytosis, but that initiation involves the following three factors: FCH domain 
only (FCHO) proteins, EGFR pathway substrate 15 (EPS15) and intersectins (Henne et al., 
2010; Stimpson et al., 2009). FCHOs contain a F-BAR domain that is able to induce mem-
brane curvature. EPS15 and intersectins are involved in recruiting clathrin adaptor proteins to 
the membrane (Fig. 5). 
Cargo selection 
After clathrin, the adaptor AP2 is the most abundant component of clathrin coated vesicle 
formation at the plasma membrane. AP2 binds PI(4,5)P2, which is specific for the plasma 
membrane, and motifs in the cytoplasmic tails of cargo proteins (McMahon and Boucrot, 
2011). In addition, cargo specific accessory adaptor proteins link AP2 to cargo molecules, 
which are not directly recognized by AP2 (Fig. 5).  
Clathrin coat assembly 
As soon as the cargo is sequestered to the nucleation site, the clathrin coat starts to assem-
ble. Clathrin triskelia are directly recruited to sites with high adaptor concentration on the 
membrane through the interaction with adaptors and clathrin-binding accessory factors. The 
polymerization of clathrin is thought to stabilize membrane curvature, but is not directly in-
ducing membrane bending (McMahon and Boucrot, 2011). Further accessory proteins like 
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epsins and amphiphysin are recruited to the edge of the forming vesicle where they induce 
further membrane invagination by their specialized curvature domains (Fig. 5).  
Vesicle scission 
BAR domain containing proteins, like amphiphysin, endophilin and sorting nexin 9, which are 
located at the vesicle neck, are recruiting the mechanochemical enzyme dynamin (Ferguson 
et al., 2009; Sundborger et al., 2011). Dynamin forms a helical collar around the neck of the 
invaginating vesicle and undergoes a GTP hydrolysis dependent conformational change 
(Sever, 2002). The mechanism of the membrane cleavage is still not absolutely clear. 
Uncoating and coat recycling 
After scission, the clathrin coat is most probably incomplete across the zone where the vesi-
cle neck was attached, leaving a defect in the clathrin cage (McMahon and Boucrot, 2011). 
At this position auxilin can bind to clathrin (Massol et al., 2006) and recruit HSP70, an 
ATPase catalysing clathrin disassembly (Schlossman et al., 1984). Conversion of PI(4,5)P2 
to PI(4)P mediated by the phosphatase synaptojanin is required for uncoating (Cremona et 
al., 1999), but how the mechanism really works is not clear. The uncoating process releases 
the clathrin machinery for reuse in a new cycle (Fig. 5) 
 
 
Fig. 5. Assembly and disassembly of a clathrin coat. 
The five steps of clathrin vesicle formation: Clathrin coated pit formation is either initiated by AP2 directly 
or indirectly via FCHOs and EPS15. The adaptor AP2 then interacts with cargo and other coat compo-
nents like clathrin. Clathrin polymerizes on the membrane, which leads to membrane deformation. The 
coat formation is stabilized by accessory factors. After coat assembly, dynamin pinches off the vesicle. In 
a further step, clathrin is quickly uncoated by the combined action of the ATPase HSP70 and auxilin 
(McMahon and Boucrot, 2011). 
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1.2. Organelle maturation 
In addition to vesicular transport some organelles undergo a so-called maturation process, 
where they change their identity by replacing their associated proteins or altering the luminal 
pH. During the maturation process, cargo molecules do not need to leave the lumen of the 
organelle. Typical examples include the cisternal maturation in the Golgi apparatus and the 
maturation of early to late endosomes. 
1.2.1. Cisternal maturation in the Golgi 
The Golgi apparatus is composed of stacks of membrane-bound structures known as cister-
nae and can be divided into the cis-, medial- and trans-cisternae plus the Trans Golgi Net-
work (TGN) (Glick and Luini, 2011). Secretory proteins from the ER enter the Golgi at the cis-
face, are transported through the Golgi where they are modified and exit at the trans-face. 
How the secretory proteins are transported through the Golgi is still not absolutely clear. For 
many years, there was the idea that Golgi cisternae are stable compartments, where the 
cargo is transported from one cisternae to the next in anterograde vesicles (Rothman and 
Wieland, 1996). This view is more and more replaced by the cisternal maturation model (Fig. 
6). In this model, new cisternae assemble at the cis-face of the Golgi from ER-derived vesi-
cles, progress through the Golgi stack and disintegrate at the TGN by forming transport car-
riers (Glick and Malhotra, 1998). Resident Golgi proteins are recycled from older to younger 
cisternae by retrograde transport in COPI vesicles (Rabouille and Klumperman, 2005). Im-
portant evidence for cisternal maturation is the progressive transport of large procollagen 
fibers, which are too large to fit into a transport vesicle, through the Golgi (Bonfanti et al., 
1998). In addition, the bulky soluble protein procollagen was observed to move through the 
Golgi stack at the same rate as the smaller transmembrane glycoprotein VSV-G (Mironov et 
al., 2001). 
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Fig. 6. Cisternal maturation model 
Golgi cisternae are transient structures formed de novo form ER-derived vesicles. A newly formed cis-
terna matures from cis to trans and breaks into transport carriers at the TGN. Maturation is driven by the 
retrograde transport of resident Golgi proteins by COPI vesicles (Glick and Luini, 2011). 
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2. Endocytic pathway 
2.1. Endocytosis 
Endocytosis is a basic cellular process and plays a role in nutrient acquisition, antigen 
presentation, clearance of apopotic cells, receptor regulation and controlling the lipid and 
protein composition of the plasma membrane. There are several pathways for internalizing 
cargo from the cell surface (Fig. 7). Some of them are constitutive, whereas others are trig-
gered by specific signals. They typically involve the formation of small vesicles. The best-
studied type of endocytosis is clathrin mediated endocytosis as described in a previous chap-
ter. Other, clathrin independent internalization routes include actin based macropinocytosis 
and phagocytosis, as well as caveolin dependent endocytosis. 
 
Fig. 7. Pathways of entry into the cell.  
Large particles can be taken up by phagocytosis, whereas fluid uptake occurs by macropinocytosis. A lot 
of cargo is also taken up by clathrin or caveolin mediated endocytosis. However, numerous cargo can be 
endocytosed by less characterized mechanisms independent of clathrin or caveolin (Conner and 
Schmid, 2003). 
 
Endocytosed molecules, including recycling receptors with their bound ligand and down-
regulated receptors, are delivered to early endosomes. In this compartment ligand and recy-
cling receptor are often separated from each other and encounter different destinies. The 
ligands and down-regulated receptors are destined for destruction in lysosomes along with 
other soluble content of the endosome, while recycling receptors are transported back to the 
plasma membrane (Gruenberg, 2001). In mammalian cells several recycling receptors like 
the low density lipoprotein (LDL) and the transferrin receptor (TfR) cycle between the plasma 
membrane and the early endosome (Trowbridge et al., 1993).  
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2.2. The endosomal/lysosomal system 
The endocytic compartment can be morphologically subdivided into early endosomes, late 
endosomes with its multivesicular appearance and lysosomes. The term ‘early endosomes’ 
actually describes two distinct endosomal organelles: the sorting and recycling endosomes 
(Maxfield and Mcgraw, 2004). 
 
Fig. 8. The endosomal/lysosomal system.  
Endocytosed material is first delivered to sorting endosomes. Once the ligand and the receptor encoun-
ter the lower pH in the lumen of the sorting endosome, the pH-sensitive ligands dissociate from their re-
ceptors. While most receptors are recycled back directly or indirectly via recycling endosomes to the 
plasma membrane, ligands and down-regulated receptors stay in the sorting endosome, which mature 
into late endosomes. Late endosomes fuse with lysosomes where its content is degraded (Huotari and 
Helenius, 2011). 
2.2.1. Sorting endosomes 
Sorting endosomes are defined as the first endocytic compartment to accept incoming cargo 
internalized from the plasma membrane. Endocytic vesicles are presumed to fuse with each 
other to form primary sorting endosomes. These structures in turn undergo homotypic mem-
brane fusion and grow (Mills et al., 1999). Sorting endosomes are located in the peripheral 
cytoplasm close to the plasma membrane and have a slightly acidic lumen with a pH of 
around 6 (Fig. 8). They consist of regions of thin tubular extensions (~60 nm diameter) and a 
globular part (~400 nm diameter) which has membrane invaginations and give rise to a multi-
vesicular appearance (Gruenberg, 2001). The globular part matures into late endosomes, 
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while the tubular extensions convert into recycling endosomes (Mellman, 1996). As their 
name implies, an important function of the sorting endosome is to target molecules to their 
correct destination. There are three possible ways: recycling to the plasma membrane, deg-
radation in the lysosome or retrieval to the TGN. In the endolysosomal system proteins can 
either travel to late endosomes and later lysosomes or are recycled back to the plasma 
membrane either directly from the sorting endosome (fast pathway) or indirectly via recycling 
endosomes (slow pathway) (Hao and Maxfield, 2000; van Dam et al., 2002). Due to the 
moderately acidic pH in the sorting endosome lumen, pH-sensitive ligands can dissociate 
from their receptors. While most of the receptors are recycled back to the plasma membrane, 
the ligands and down-regulated receptors accumulate in the vesicular region of the sorting 
endosome which leads to the degradative pathway (Jovic et al., 2010).  
Sorting endosomes are positive for Rab5 and early endosome antigen 1 (EEA1). In addition, 
Rab4 is also localized to sorting endosomes (van der Sluijs et al., 1991), but likewise to 
Rab11-positive recycling endosomes (Trischler et al., 1999). Organelles are defined by their 
lipid composition. Sorting endosomes are enriched in phosphoinositol-3-phosphate (PI(3)P) 
helping to manifest its identity (Behnia and Munro, 2005).  
In the globular part of the sorting endosome, intraluminal vesicle (ILV) formation already be-
gins. The cytosolic surface of the sorting endosome membrane has characteristic plaques 
containing clathrin and components of the endosomal sorting complex required for transport 
(ESCRT), which is responsible for the sorting of ubiquitinated membrane proteins into ILVs 
(Raiborg and Stenmark, 2002).  
2.2.2. Recycling endosomes 
As mentioned above, there are two main routes to recycle receptors back to the cell surface: 
Either via the fast recycling directly form the sorting endosomes or via the slow recycling indi-
rectly over the recycling endosomes (Fig. 8). Recycling endosomes are mainly a collection of 
tubular structures associated with microtubules, which are thought to be pinched off from the 
main body of the sorting endosomes. They have a perinuclear localization in the cell and are 
less acidic than sorting endosomes (pH 6.4-6.5) (Taguchi, 2013). Specific surface proteins 
such as Rab11 can be used as a marker for recycling endosomes (Trischler et al., 1999). A 
well-studied receptor using the slow recycling pathway is the low density lipoprotein receptor 
(LDLR). LDL is released from the LDLR in the sorting endosomes and transported to the 
lysosomes, while the receptor recycles back to the plasma membrane via recycling endo-
somes (Maxfield and Mcgraw, 2004). 
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2.2.3. Late endosomes 
Late endosomes are derived from the vacuolar domains of sorting endosomes. How the con-
version occurs is still under debate. The classical model envisages a vesicular transport be-
tween the two endosomes. Endosomal carrier vesicles would serve as transporters of cargo 
from sorting endosomes to late endosomes (Vonderheit and Helenius, 2005). This view is 
more and more challenged by the maturation model. Here the sorting endosome is trans-
formed into a late endosome by a Rab conversion (discussion in further detail later), which 
predicts no vesicular transport (Rink et al., 2005).  
Late endosomes formed in the peripheral cytoplasm from sorting endosomes move to the 
perinuclear area of the cell (Huotari and Helenius, 2011). Mature late endosomes are typical-
ly round or oval and have a diameter of 250-1000nm. Their lumen has a pH of 5-6 and they 
are located near the nucleus. Late endosomes are defined to be Rab7 and PI(3,5)P2 positive 
and already contain some hydrolases, but they are not able to digest all the material. There-
fore proteins destined for degradation are transported further to lysosomes. 
Newly formed late endosomes undergo a multitude of changes by the time they fuse with 
lysosomes having almost no similarities with sorting endosomes anymore. The maturation 
process involves the following main steps (Huotari and Helenius, 2011) (Fig. 8):  
1. Rab conversion: Rab5 is exchanged with Rab7. This process will be discussed in further 
detail in the Rab conversion chapter. 
2. Formation of intraluminal vesicles (ILVs): Ubiquitinated cargo recruits the ESCRT machin-
ery that induces inward-budding of membrane containing specific membrane proteins and 
lipids destined for degradation. 
3. Acidification: The luminal pH drops from 6.5 to 5-6 through the action of V-ATPases. 
4. Phosphoinositiol conversion: PI(3)P is converted to PI(3,5)P2. 
5. Loss of recycling with the plasma membrane 
6. Gain of lysosomal hydrolases and membrane proteins: Many newly synthesized acid hy-
drolases are delivered to late endosomes after they are tagged with mannose-6-phosphate 
(M6P) in the Golgi and then bind mannose-6-phosphate receptor (M6PR) in the TGN. In the 
late endosomes, the hydrolases dissociate from the receptors as a result of the low pH and 
the receptors are recycled back to the TGN. 
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2.2.4. Lysosomes 
The mechanism of transfer of endocytosed material from endosomes to lysosomes is contro-
versial. There are four possible models: maturation model, vesicular transport model, kiss-
and-run model and hybrid model (Luzio et al., 2007). The kiss-and-run model describes a 
continuous cycle of transient contacts between late endosomes and lysosomes, while in the 
hybrid model the two organelles fuse to form a hybrid organelle, followed by a fission event 
(Fig. 9).  
Lysosomes are the main site for intracellular digestion and are organelles of heterogeneous 
size. They have a perinuclear localisation and Lamp1 is a typical marker. Two classes of 
proteins are essential for the function of lysosomes: acid hydrolases and integral lysosomal 
membrane proteins (LMPs). Lysosomes contain about 50 types of acid hydrolases including 
proteases, nucleases, glycosidases, lipases, phosholipases, phosphatases and sulfatases. 
The lysosome with a luminal pH of 5.0 to 5.5 provides the environment for optimal hydrolase 
activity. The hydrolases are mainly transported via the M6P receptors to late endosomes and 
reache the lysosomes via the endocytic pathway. 
 
Fig. 9. Delivery to lysosomes 
Different models have been proposed to explain the transport from late endosomes to lysosomes. In the 
first model late endosomes mature into lysosomes, while in the second model a vesicular transport be-
tween the two organelles takes place. In the third model, late endosomes and lysosomes can partially 
fuse to allow exchange of content before they separate again (kiss-and-run model). In the last model, 
late endosomes and lysosomes fuse to a hybrid organelle (Luzio et al., 2007).  
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The mammalian lysosome contains around 25 LMPs. They are mainly located in the lysoso-
mal limiting membrane and have diverse functions like lysosomal acidification, protein import 
from the cytosol, membrane fusion and transport of degradation products to the cytosol. The 
most famous LMPs are the lysosome associated membrane proteins (LAMPs) (Saftig and 
Klumperman, 2009). Not so much is known about the transport of LMPs to lysosomes. A 
fraction of the LMPs that exit the TGN reaches the plasma membrane over the secretory 
pathway and travel then to the lysosomes via the endocytic pathway. But there are also di-
rect ways from the TGN to the endolysosomal system. 
 
3. Retrograde transport from endosomes to the TGN 
Retrograde transport from endosomes to the TGN is only partially involved in the endocytic 
pathway since this pathway is mainly used by endogenous membrane-bound proteins like 
acid hydrolase receptors, which cycle between endosomes and the TGN. However, to some 
extent, these proteins are also present at the plasma membrane. Following their internaliza-
tion into early endosomes, they return to the TGN showing the existence of a plasma mem-
brane-endosome-TGN pathway (Fig. 10) (Bonifacino and Rojas, 2006).  
 
Fig. 10. Sorting of an acid hydrolase receptor 
Mannose-6-phosphate receptor (M6PR), a typical acid hydrolase receptor, cycles between the TGN and 
endosomes. Clathrin coats mediate exit of M6PR bound to hydrolases from the TGN. In the endosomes, 
the hydrolases dissociate from the M6PRs as a result of the low pH and the receptors are recycled back 
to the TGN via the retromer complex. A small subset of M6PR is also present at the plasma membrane, 
where it is internalized and joins the pool of the recycling M6PR in the endosomes (Bonifacino and Hur-
ley, 2008). 
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Cargos like acid-hydrolase receptors, transmembrane enzymes and SNARES are transport-
ed from endosomes to the TGN by the retromer complex. In mammalian cells, the retromer 
complex consists of sorting nexin (SNX) dimers and a VPS26-VPS29-VPS35 trimer 
(McGough and Cullen, 2011). SNX proteins form specific homo- or heterodimers via their 
BAR-domains, which induces high membrane curvature and are recruited to endosomal 
membranes by binding to PI(3)P with their Phox-homology (PX)-domains (Bonifacino and 
Hurley, 2008). The VPS26-VPS29-VPS35 complex is then recruited through interactions with 
the N-termini of the SNXs. The VPS35 subunit is responsible for the selection of retrograde 
cargo proteins into retromer coated membrane domains (Bonifacino and Rojas, 2006). 
There are also other retrograde transport mechanisms such as clathrin mediated transport. 
Clathrin coated carriers are involved in transport of Shiga toxin and the TGN markers TGN38 
and TGN46 from endosomes to the TGN (Saint-Pol et al., 2004). 
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4. Multivesicular body formation 
Multivesicular bodies (MVBs) are late endosomes containing intraluminal vesicles (ILVs). A 
subset of transmembrane proteins and lipids are sorted into these vesicles. Upon fusion with 
the lysosome, the ILVs are exposed to hydrolases and are degraded (Babst, 2011). The pro-
teins inducing intraluminal vesicle formation form the endosomal sorting complex required for 
transport, short ESCRT. The ESCRT machinery consists of four sub-complexes: ESCRT-0, -
I, -II and -III plus several accessory components (Table 1) (Raiborg and Stenmark, 2009). 
 
Table 1: ESCRT subunits and accessory components (Raiborg and Stenmark, 2009) 
Studies on endosomal membranes have suggested that late endosomes contain lipid rafts 
rich in cholesterol and sphingomyelin (Sobo et al., 2007), but are also enriched in phospho-
inositol-3-phosphate (PI(3)P). It is proposed that intraluminal vesicles are formed from these 
lipid rafts, since the vesicles contain a high amount of cholesterol (Möbius et al., 2003). This 
model is also supported by the fact that HRS, a subunit of ESCRT-0, can bind to PI(3)P 
(Raiborg et al., 2001b) and sort ubiquitinated membrane proteins into these domains. Mem-
brane proteins destined for degradation are mono-ubiquitinated at multiple sites or polyubiq-
uitinated via the ubiquitin-lysine 63. Both subunits of ESCRT-0 possess several motifs inter-
acting with ubiquitin (MIU) (Hirano et al., 2006), which strengthen overall ubiquitin binding. 
Enhanced complex sorting function was also shown by the binding of HRS to clathrin through 
a C-terminal clathrin box motif (Fig. 11a) (Raiborg et al., 2001a).  
ESCRT-I and ESCRT-II are likely to function when ubiquitin-containing cargo has already 
been concentrated by ESCRT-0. These two complexes also have one ubiquitin binding motif 
and it has been proposed that cargo could be handed over from one complex to the other, 
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but the mechanism is not clear yet (Raiborg and Stenmark, 2009). In addition to the role in 
cargo sorting, ESCRT-I might contribute to membrane deformation. ESCRT-I in yeast spans 
about 25 nm, which is approximately the size of ILVs in yeast (Kostelansky et al., 2007). 
ESCRT-III is so far the best-characterized component of the whole machinery that can drive 
membrane deformation. In vivo, high levels of the ESCRT-III subunit VPS32/CHMP4 causes 
the formation of curved polymeric spirals on membranes (Hanson et al., 2008). These spirals 
are able to induce negative curvature in the membrane, which gives rise to membrane tu-
bules that are extruded away from the cytoplasm (Fig. 11b). During this process, cargo is 
deubiquitinated by Doa4, which is recruited by ESCRT-III. Deubiquitination mediates the re-
cycling of ubiquitin, thereby avoiding depletion of the cellular ubiquitin pool (Swaminathan et 
al., 1999).  
How membrane abscission occurs, is still not clear. One possible model is that ESCRT-III 
assembles into circular arrays and narrows the neck of the invaginating vesicle. The ATPase 
VPS4 may then drive abscission through removal of individual ESCRT-III subunits at the 
neck of the invagination (Fig. 11c) (Henne et al., 2011).  
 
Fig. 11. MVB formation 
a) Initial recognition of ubiquitinated cargo is mediated by ESCRT-0, which concentrates in lipid rafts 
containing PI(3)P and clathrin microdomains. b) ESCRT-III induces negative curvature in the membrane, 
which gives rise to membrane tubules that are extruded away from the cytoplasm. c) Together with 
ESCRT-III VPS4 causes scission of the vesicles. (Saksena et al., 2009) 
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5. Rab proteins 
The transfer of contents between distinct membrane-enclosed organelles is fundamental to 
the existence of eukaryotic cells. Central in ensuring that cargoes are delivered to their cor-
rect destinations are the Rab proteins, a ubiquitously expressed family of small monomeric 
Ras-like GTPases (Stenmark, 2009). 11 Rabs have been identified in yeast Saccharomyces 
cerevisiae and over 60 in mammalian cells (Grosshans et al., 2006). Like other GTPases, 
Rabs switch between two conformations, an inactive form bound to GDP (guanosine diphos-
phate), and an active form bound to GTP (guanosine triphosphate). GDP to GTP exchange 
is catalysed by guanine nucleotide exchange factors (GEFs), which facilitate GDP release. 
The high cytosolic concentration of GTP ensures that GTP quickly binds as soon as GDP is 
released from the Rab (Zerial and McBride, 2001). GTP hydrolysis is driven by the intrinsic 
GTPase activity of the Rab protein itself but also catalyzed by a GTPase-activating protein 
(GAP) (Stenmark, 2009). Rabs also undergo a membrane insertion and extraction cycle that 
is partially coupled to the nucleotide cycle. Rabs are anchored via prenyl groups on two cys-
teines in the C-terminus. Upstream of the prenyl anchor is a hypervariable region that highly 
differs between Rab proteins, which plays a role in correct membrane targeting (Chavrier et 
al., 1991). 
GDP dissociation inhibitor (GDI) recognizes GDP-bearing Rabs, binds the hydrophobic, in-
soluble prenyl groups and carries the Rab proteins through the cytoplasm to its appropriate 
target membrane (Pfeffer, 2013). Membrane attachment of Rab proteins requires the func-
tion of a GDI displacement factor (GDF). Once dissociated from GDI the lipid prenyl groups 
can then insert into the membrane, anchoring the Rab proteins at the cytoplasmic face of a 
vesicle or the target membrane (Grosshans et al., 2006). The active membrane-bound Rabs 
are then able to fulfil their various functions in membrane traffic by binding to specific factors 
called effectors. By definition, effector proteins can only bind to their specific Rab proteins in 
their GTP bound form (Fig. 12).  
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Fig. 12. Scheme of the Rab-GTP/GDP cycle.  
Conversion of the GDP-bound Rab into the GTP-bound form occurs through GEFs. The active Rab-GTP 
is recognized by effector proteins, which can then fulfil their function. The active form is converted back 
to inactive Rab-GDP through GTP hydrolysis, which is stimulated by GAPs. Inactive Rab is then bound 
to GDI, which masks the prenyl group and keeps the Rab in a soluble cytosolic form. With the help of 
GDF, the Rab protein gets membrane attached again and the cycle can start form the begining (Gross-
hans et al., 2006). 
 
The highly selective distribution of specific Rabs on the membranes makes them ideal mo-
lecular markers for identifying each membrane type and guiding vesicular traffic between 
them. Specific Rab proteins have been shown to regulate the following for steps in transport 
reactions: vesicle budding, uncoating, motility, and fusion (Stenmark, 2009). 
Vesicle budding 
It has been shown that several Rab GTPases are involved in cargo specific coat assembly 
during vesicle budding. A prime example involves Rab9 at late endosomes. Rab9 recruits its 
effector TIP47, which binds to the cytosolic tail of mannose-6-phosphate receptor (M6PR) 
and is required for the transport of the receptor from late endosomes to the TGN (Díaz and 
Pfeffer, 1998). 
Uncoating 
Rab proteins also participate in vesicular uncoating. Endocytic vesicles from the plasma 
membrane contain among other components the adaptor complex AP2 and Rab5. AP2 
needs to be phosphorylated at its µ2-subunit to interact with cargo and requires the binding to 
PI(4,5)P2 to be recruited to the membrane. After scission of the vesicle from the plasma 
membrane, Rab5 binds to its effector GAPVD1 which coordinates uncoating by promoting 
dephosphorylation of µ2-subunit and increasing PI(4,5)P2 turnover (Semerdjieva et al., 2008). 
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Motility 
Vesicles are often actively transported through the cell by using either actin- or microtubule-
dependent motors. Some motor proteins can directly bind to Rab proteins. Rab6-GTP binds 
to the microtubule motor Rabkinesin6 and thus promotes the delivery of vesicles from the 
Golgi to the ER (Echard et al., 1998). More often, Rabs indirectly interact with motor proteins. 
Rab27a, for example, recruits the effector melanophillic to melanosomes. Melanophilic in 
turn binds to the motor myosin Va, thereby shuttling the melanosomes towards the cell pe-
riphery (Kuroda and Fukuda, 2004). 
Vesicle fusion 
In the last step of vesicle transport, Rab tethering effectors are involved. Rab5 is essential for 
homotypic early endosome fusion as well as heterotypic endocytic vesicle to endosome fu-
sion. It indirectly influences this processes by recruiting the tethering effector EEA1 and 
Rabenosyn5, which in turn interact with SNARE proteins (Nielsen et al., 2000; Simonsen et 
al., 1999). 
In the next chapters, some Rab proteins involved in the endolysosomal system are explained 
in further detail. 
5.1. Rab5 
Rab5 is involved in several different functions and is localized to early endosomes, clathrin 
coated vesicles, and the plasma membrane. Its traditional role lies in targeting plasma-
membrane-derived vesicles to endosomes and in homotypic fusion between early endo-
somes (Bucci et al., 1992; Gorvel et al., 1991). Rab5 is a rate-limiting component in mem-
brane docking or fusion in the early endocytic pathway. A GTPase-deficient mutant, 
Rab5Q79L, stimulates endocytosis and early endosome fusion leading to enlarged early en-
dosomes, whereas a mutant with a greater affinity for GDP, Rab5S34N, inhibits these pro-
cesses (Stenmark et al., 1994). 
The role of Rab5 on the plasma membrane was for a long time neglected. A small fraction of 
Rab5 is localized to the plasma membrane and several in vitro studies indicate that Rab5 
contributes directly to clathrin mediated endocytosis. Ligand uptake during in vitro endocyto-
sis depends on the presence of Rab5-GDP bound to GDI (McLauchlan et al., 1998), whereas 
Rab5-GDP bound to GDI undergoes GDP/GTP exchange when incubated with purified clath-
rin coated vesicles (Horiuchi et al., 1995). Rab5 also affects protein sorting within endo-
somes (de Renzis et al., 2002) and is involved in the attachment and movement of early en-
dosomes along microtubules (Nielsen et al., 1999). 
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On endosomes, a lot of different Rab5-interacting proteins were found. These proteins in-
clude Rabaptin5 (Stenmark et al., 1995), Rabenosyn5 (Nielsen et al., 2000), Vps34 (Christo-
foridis et al., 1999b)  and EEA1 (Christoforidis et al., 1999a). 
5.2. Rab4 
The monomeric GTPase Rab4 is associated with early endosomes and is supposed to regu-
late recycling from endosomes to the plasma membrane. However, its role in this recycling 
process is not absolutely clear. Overexpression of wildtype Rab4 reduces the intracellular 
accumulation of the tracer horse radish peroxidase and transferrin receptors are redistributed 
from endosomes to the plasma membrane (Mohrmann and van der Sluijs, 1999). It also 
blocks iron discharge by preventing the delivery of transferrin to acidic early endosomes, 
instead causing transferrin accumulation in a population of nonacidic vesicles and tubules. 
Rab4 thus appears to control the function or formation of recycling endosomes (van der Slu-
ijs et al., 1992). In an in vitro study, depletion of Rab4 from cytosol blocked the formation of 
recycling vesicles, indicating that Rab4 is required to generate endosome-derived vesicles 
(Pagano et al., 2004). siRNA mediated knockdown of Rab4 in HeLa cells showed contradict-
ing results. In one study transferrin receptor recycling was enhanced by Rab4 knockdown 
(Deneka et al., 2003), while the recycling rate was decreased in another study (Yamamoto et 
al., 2010). 
Rab4-GTP is membrane bound while Rab4-GDP has a cytosolic distribution. To see if this is 
important, chimeric Rab4 proteins were created in which the carboxyl-terminal prenylation 
motif was replaced by the transmembrane domain of cellubrevin (Mohrmann, 2002). Due to 
this replacement the protein was permanently attached to the membrane. The chimeric Rab4 
was still properly targeted to early endosomes and bound GTP to the same extent as 
wildtype Rab4, but recycling of the transferrin receptor was less efficient than with wildtype 
Rab4. This indicated that Rab4 function requires on-going cycles of association and dissocia-
tion with the membrane (Mohrmann, 2002). 
As with many other Rabs, Rab4 interacts with specific effectors like Rabaptin5 (Vitale et al., 
1998), Rabenosyn5 (de Renzis et al., 2002) and Rabip4 (Fouraux et al., 2004). 
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5.3. Rab11 
By immunofluorescence and electron microscopy it was shown that Rab11 colocalizes with 
internalized transferrin in recycling endosomes of CHO and BHK cells (Ullrich et al., 1996). 
Rab11 is involved in recycling of receptors to the plasma membrane because early steps of 
uptake of transferrin were not affected by overexpressing Rab11. Dominant negative 
Rab11S25N inhibited transport of internalized transferrin from recycling endosomes to the 
plasma membrane and caused fragmentation of this compartment. Transfection of the domi-
nant positive Rab11Q70L lead to compaction of the recycling endosome, but also inhibited 
transferrin recycling (Ullrich et al., 1996). Ren et al. (1998) used a low temperature block to 
inhibit transport between sorting and recycling endosomes. They could show that 
Rab11S25N inhibits transferrin recycling, whereas Rab11Q70L and wildtype Rab11 did not 
have this effect (Ren et al., 1998). It seems that the active Rab11-GTP is required for the exit 
of the transferrin receptor. 
In addition to these reports linking Rab11 activity to endocytic pathways, other reports sug-
gested a role for Rab11 in biosynthetic exocytic membrane traffic. In PC12 cells, Rab11 was 
detected in association with TGN and TGN-derived secretory vesicles (Urbé et al., 1993). In 
BHK cells, overexpression of dominant-negative Rab11S25N decreased delivery of the ba-
solaterally targeted vesicular stomatitis virus (VSV) G protein from the Golgi to the cell sur-
face (Chen et al., 1998), and expression of wildtype Rab11 accelerated delivery of new pro-
tease-activated receptors to kidney epithelial cell surfaces following trypsin exposure (Roos-
terman et al., 2003) 
5.4. Rab7 
Rab7 is associated primarily with late endosomes and is the only Rab protein that is at least 
partially localized to lysosomes (Méresse et al., 1995). Wildtype Rab7 allowed normal 
transport of VSV G protein from the plasma membrane to late endosomes, while a dominant 
negative mutant caused an accumulation of VSV G protein in early endosomes. Further was 
shown that Rab7 function was not required for early internalization of cargo, but was crucial 
in downstream degradative events (Feng et al., 1995). Another study showed a marked inhi-
bition of the degradation of low density lipoproteins (LDL) in cells expressing a dominant 
negative Rab7 (Vitelli et al., 1997). Press et al. (1998) observed that dominant negative Rab7 
caused a redistribution of mannose-6-phosphate receptor (M6PR) from its late endosomal 
localization to early endosomes (Press et al., 1998). In summary, all the data suggest a key 
role of Rab7, downstream of Rab5, in regulating membrane transport leading from early to 
late endosomes. 
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6. Rab GEFs 
As described above, Rab GEFs enhance the release of GDP from Rab proteins, thereby 
facilitating nucleotide exchange. A recent study has shown that Rab GEFs can provide the 
minimal machinery needed to target one Rab to a specific membrane in the cell. For this, 
Rab GEFs were fused to mitochondrial outer membrane targeting sequences and the effect 
on different Rabs were observed. With this approach, it was possible to specifically target a 
selection of Rab proteins to their cognate GEFs at mitochondria (Blümer et al., 2013).  
 
6.1. Rabex5 
Rabex5 is a guanine nucleotide exchange factor (GEF) for Rab5 on early endosomes and 
was originally identified as an interaction partner of Rabaptin5 (see chapter Rab effectors). 
They form a stable complex and are coimmunoprecipitated with one another. That is why 
Horiuchi et al. (1997) named the protein Rabex5 for Rabaptin5-associated exchange factor 
for Rab5. Rabex5 contains multiple functional domains. In the middle of the protein resides 
the GEF catalytic core, which consists of a VPS9 domain and an adjacent N-terminal helical 
bundle. A coiled-coil domain downstream of the GEF domain mediates the binding to Rabap-
tin5, whereas a zinc-finger domain at the N-terminus is shown to bind ubiquitin (Fig. 12). 
 
Fig. 13. Domain organization of Rabex5 
At the N-terminus, the zinc-finger motif (ZnF) and the motif interacting with ubiquitin (MIU) are located. In 
the middle is an early endosome targeting (EET) domain consisting of the membrane-binding motif 
(MBM) and the helical bundle (HB). The GEF catalytic core in cludes the helical bundle (HB) and the 
VPS9 module. The C-terminus comprises the coiled-coil domain (CC) interacting with Rabaptin5 fol-
lowed by a proline-rich region (PR). 
The middle sequence of Rabex5 shares high sequence homology with VPS9, which is the 
GEF for the yeast homologue of Rab5 (Horiuchi et al., 1997). The structure of the catalytic 
core was solved showing an N-terminal bundle domain (HB) and the VPS9 domain. In addi-
tion, Rabex5 did not only show catalytic activity for Rab5 but also for the closely related 
Rab21. Furthermore, four amino acids could be identified, that are essential for the GEF ac-
tivity: Asp313, Pro317, Tyr354 and Thr357 (Delprato et al., 2004).  
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Full-length Rabex5 shows very little GEF activity in vitro and requires interaction with 
Rabpatin5, a Rab5 effector, to gain full activity (Lippé et al., 2001) or endosomal membrane 
association (Zhu et al., 2007). In a yeast two-hybrid assay, Mattera et al. (2006) could show 
that Rabex5 binds to Rabaptin5 via a coiled-coil domain downstream of the GEF catalytic 
core. In an attempt to crystalize the Rabex5 GEF catalytic core in complex with nucleotide-
free Rab21, an autoinhibitory element in an amphiphatic helix located near the C-terminus of 
the VPS9 domain was discovered. This autoinhibitory element overlaps with the Rabaptin5 
binding site. Autoinhibition could be released by binding of Rabaptin5 to this element (Del-
prato and Lambright, 2007), also explaining the higher GEF activity of Rabex5 complexed to 
Rabaptin5 as shown by Lippe et al (2001).  
Another study showed that Rabex5 could be targeted to early endosomes independent of 
Rabaptin5. They identified an early endosome targeting (EET) domain composed of a mem-
brane targeting motif (MBM) and the helical bundle (HB) also used by the GEF catalytic core. 
Mutants missing the Rabaptin5 binding domain were able to recruit to early endosomes and 
activate Rab5 independently of Rabaptin5 in vivo (Zhu et al., 2007).  
In addition to its function as a Rab5 GEF, Rabex5 also binds ubiquitin and undergoes ubiqui-
tin binding-dependent monoubiquitination (Lee et al., 2006; Mattera et al., 2006; Penengo et 
al., 2006). The N-terminal zinc-finger (ZnF) motif has ubiquitin ligase activity (Lee et al., 
2006; Mattera et al., 2006), while the following motif interacting with ubiquitin (MIU) binds 
ubiquitin (Lee et al., 2006; Penengo et al., 2006). Mattera et al. (2008) demonstrated that 
ubiquitin binding is essential for Rabex5 recruitment to endosomes and that monoubiqui-
tinated Rabex5 is enriched in the cytosol. They proposed a model where ubiquitin binding-
dependent monoubiquitination results in dissociation of Rabex5 from endosomes to the cyto-
sol thereby causing an intramolecular binding of the ubiquitin to the ZnF/MIU domains. 
Deubiquitination of Rabex5 releases this interaction allowing again endosome recruitment 
(Mattera and Bonifacino, 2008). 
In summary, the data suggests three different ways of Rabex5 recruitment to endosomes: 
First via the Rab5 effector Rabaptin5, second via the early endosome targeting domain, and 
finally by binding to ubiquitinated cargo. To what extend each pathway contributes to the final 
picture is not clear yet.  
  
Introduction   
   
 
 
35 
6.2. RME6 
While Rabex5, the GEF that is mainly required to activate Rab5 on early endosomes, is well- 
characterized, not much is known about GEFs acting at the plasma membrane. In 2005, 
Sato et al. characterized RME6 as a novel nucleotide exchange factor for Rab5 at the plas-
ma membrane. RME6 was identified in a screen for C. elegans mutants that are defective in 
receptor-mediated endocytosis. As for Rabex5, RME6 possesses a Vps9 GEF domain. Its 
specificity for Rab5-GDP was shown by yeast two-hybrid and co-immunoprecipitation exper-
iments with dominant negative Rab5 (Sato et al., 2005). It could be shown that RME6 colo-
calized with clathrin at the plasma membrane and that localization of RME6 to the plasma 
membrane disappeared when clathrin was silenced (Sato et al., 2005), suggesting that 
RME6 localization depends on recruitment to clathrin coated structures. Vesicle formation 
and subsequent removal of the clathrin coat occurred normally in RME6 mutants but fusion 
of the vesicle with early endosomes was inhibited by the lack of active Rab5 (Sato et al., 
2005). 
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7. Rab effectors 
The activated Rab proteins bind to soluble factors that act as effectors to transduce the sig-
nal of the Rab GTPase (Zerial and McBride, 2001). By definition Rab effectors recognize the 
GTP-bound form of a Rab GTPase. Many different effector proteins have been identified and 
characterized through a variety of approaches. Various modes of Rab coordination by Rab 
effectors have been proposed (Fig. 14) (Stenmark, 2009): Firstly, a positive feedback loop, 
where one Rab protein recruits it own GEF, thus maintaining the membrane’s Rab identity. 
Secondly, effector coupling, where the effector of one Rab also interacts with another and 
thereby coordinates or couples different Rab domains or Rab activities in the same mem-
brane. Thirdly, activation coupling, where one Rab recruits the GEF of a second Rab protein 
in a feedforward manner, and finally, Rab conversion, where the first Rab recruits the GEF of 
the second which then recruits a GTPase activating protein (GAP) for the first, thereby com-
pleting the full transition from one Rab identity of the membrane to the next. 
 
 
Fig. 14. Coordination of Rab functions by effector proteins 
a) Positive feedback: One Rab protein recruits it own GEF 
b) Effector coupling: The effector of one Rab also interacts with another Rab 
c) Activation coupling: One Rab recruits the GEF of a second Rab 
d) Rab conversion: The first Rab recruits the GEF of the second which then recruits a GAP for the first 
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7.1. Rabaptin5 
Rabaptin5 is generally considered the prime example of a Rab effector involved in positive 
feedback and effector coupling. It is a cytosolic protein recruited to transferrin-positive endo-
somes and consists of 862 amino acid residues. There are several Rabaptin5 isoforms (Ra-
baptin5α, Rabaptin5γ, Rabpatin5δ) in human cells as a result of differential splicing varying 
only in small insertions or deletions (Korobko et al., 2002). It was found that Rabaptin5 di-
merizes through N- and C-terminal sequences predicted to form coiled coil structures (Fig. 
15). Coiled-coil domains consist of seven amino acid repeats where positions one and four 
are non-polar and positions five and seven are mainly polar. Their overall secondary struc-
ture is α-helical and the interaction between two helices result in efficient burial of the hydro-
phobic side-chains at their interface (Vitale et al., 1998). 
 
Fig. 15. Domain organization of Rabaptin5 
Rabaptin5 dimerizes through the indicated coiled coil structures (CC1-1, CC1-2, and CC2-1, CC2-2). At 
the N-terminus the Rab4 and one Rab5 binding domain are located. An AP1 binding site is in the middle 
of the protein, whereas Rabex5 binds to CC2-1 region. A second Rab5 binding domain is found in the C-
terminus of the protein. 
Rabaptin5 was originally identified in a yeast two-hybrid screen using GTPase-deficient Rab5 
as a bait (Stenmark et al., 1995). It got its name from the Greek word apto, which means 
touch: Rabaptin5 is in touch with Rab5.  
A conserved 73 amino acid sequence at the C-terminus of Rabaptin5 was shown to be nec-
essary and sufficient for the interaction between Rab5 and Rabaptin5 (Vitale et al., 1998). A 
later crystallization of Rab5 together with the C-terminal domain of Rabaptin5 could narrow 
this interaction to only 20 amino acids at the very C-terminal end of Rabaptin5 (Zhu et al., 
2004). For a long time, this was thought to be the only Rab5 binding domain. In 2006, how-
ever, Korobko et al. found in a yeast two-hybrid screen a second, N-terminal Rab5 binding 
domain comprising amino acids 216-318 (Korobko et al., 2006). 
As mentioned in the Rabex5 chapter, Rabaptin5 forms a stable complex with Rabex5 (Horiu-
chi et al., 1997) and plays an important role in early endosome fusion. A widely accepted 
model has been described by Zerial et al. (2001). Initial Rabex5 recruitment to early/sorting 
endosome occurs either via its early endosome targeting domain or via the interaction with 
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ubiquitinated cargo (see Rabex5 chapter). Rabex5 then recruits Rab5 to the endosome and 
converts it to its active GTP-bound form, which becomes anchored to the membrane. The 
active Rab5 in turn is then able to interact with its effectors, including Rabaptin5. Rabaptin5 
via the bound Rabex5 increases the production of Rab5-GTP. These interactions generate a 
positive feedback loop, which counteracts inactivation of Rab5 through its GAP (Grosshans 
et al., 2006). In this way, activated Rab5 is specifically concentrated at the early endosome 
(Fig. 16). Among the Rab5 effectors recruited to Rab5-GTP is VPS34, a phosphoinositol-3-
kinase (PI(3)K), which causes an enrichment of PI(3)P on early endosomes (Zerial and 
McBride, 2001). The concomitant presence of Rab5-GTP and PI(3)P allows then the recruit-
ment of the Rab5 effectors early endosome antigen 1 (EEA1) and Rabenosyn5, which are 
important for docking and early endosome fusion (Fig. 16) (Zerial and McBride, 2001).  
Vitale et al. (1998) found in a yeast two-hybrid screen a second Rab-binding domain, which 
is located from amino acid 5 to 135 in the N-terminus of Rabaptin5 and mediates the direct 
interaction with GTP-bound Rab4. A later study, however, showed an interaction of Rabap-
tin5 with Rab4 between amino acid 140 and 295 with a GST-Rab4 pull-down (Deneka et al., 
2003). This is in agreement with the observation of Korobko et al. (2005) that the splice vari-
ant Rabaptin5δ, missing residues 187 to 226, cannot interact with Rab4. All agree on a Rab4 
binding domain in the N-terminal third of Rabaptin5, but the exact position is still under de-
bate. The contribution of the Rab4-binding domain in Rabaptin5 appeared to be reflected in 
an observed increase of Rab4 and Rab5 double-positive endosomes (de Renzis et al., 
2002), supporting the notion of Rabaptin5 coordinating or coupling these two Rabs and their 
effector networks. 
In vitro and in vivo studies both showed that the Rabaptin5/Rabex5 complex interacts with γ-
ear domain of AP1 and with GGAs (Mattera et al., 2003). There are two interaction sites be-
tween GGAs and Rabaptin5. The GGA-GAT domain binds to the C-terminal coiled-coils of 
Rabaptin5 (residues 551-862). The second interaction of GGA lies in the GAE domain that 
recognizes an FGPLV sequence (residues 439-443) in a predicted unstructured segment of 
Rabaptin5. The FGPLV sequence in Rabaptin5 is made up of hydrophobic amino acid resi-
dues that bind to the hydrophobic grooves on the GGA-GAE and γ-adaptin ear domains of 
AP1 (Mattera et al., 2003). Interestingly the GGA-Rabaptin5 interaction reduces binding of 
clathrin to the hinge domain of GGA. This could suggest that binding of Rabaptin5/Rabex5 
may induce the release of clathrin from GGA-coated intermediates or prevent clathrin bind-
ing, thereby inhibiting vesicle formation (Mattera et al., 2003). 
Another group investigated the role of Rabaptin5α (splice variant of Rabaptin5) and its puta-
tive partner γ1-adaptin in membrane recycling (Deneka et al., 2003). In agreement with Mat-
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tera et al. (2003), they could show that the binding site for γ1-adaptin is in the hinge region of 
Rabaptin5α. Co-expression of Rabaptin5α and γ1-adaptin showed a colocalization in a Rab4-
dependent manner on recycling endosomes (Deneka et al., 2003). Cells transfected with 
Rabaptin-5α alone were unable to support recycling of internalized transferrin receptor. But 
receptor recycling could be restored by overexpression of Rabaptin-5α together with γ1-
adaptin.  
 
Fig. 16. Model of Rab5 activation on early endosomes 
Rabex5 activates Rab5 on early endosomes. Rab5-GTP is then able to interact with Rabaptin5. Rabap-
tin5 in turn binds to Rabex5 and increases the production of Rab5-GTP. These interactions generate a 
positive feedback loop. Active Rab5 also activates VPS34, which converts PI into PI(3)P. This phosphor-
ylated PI together with Rab5 allows the recruitment of EEA1 and Rabenosyn5, which finally leads to 
membrane fusion. As Rabaptin5 interacts with Rab5 and Rab4 through independent sites, it is supposed 
to function as a molecular linker between endocytic and recycling traffic (according to Zerial and McBride 
2001). 
 
7.2. VPS34 
VPS34 is a phosphoinositol-3-kinase (PI(3)K), which catalyzes the phosphorylation of phos-
phoinositol (PI) to phosphoinositol-3-phosphate (PI(3)P). It is thought to be one of the first 
Rab5 effectors recruited to early endosomes (Christoforidis et al., 1999b). Through the pres-
ence of Rab5-GTP and the production of PI(3)P, other Rab effectors such as EEA1 (Lawe et 
al., 2000) or Rabenosyn5 (Nielsen et al., 2000) are specifically recruited to early endosomes. 
VPS34 plays a crucial role in early endosome function since treatment of cells with the 
PI(3)K inhibitors Wortmannin (Ui et al., 1995) and LY294002 (Vlahos et al., 1994) prevented 
localization of PI(3)P-binding proteins (Patki et al., 1997) and impaired transferrin trafficking 
from early endosomes (van Dam et al., 2002). 
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7.3. Early endosome antigen 1 (EEA1) 
Originally identified as a Lupus autoantigen with restricted localization to early endosomes, 
EEA1 consists of an N-terminal FYVE domain, four long heptad repeats with the Rab5 inter-
action site and a C-terminal region containing a calmodulin binding (IQ) motif (Fig. 17) (Mu et 
al., 1995). It forms a parallel coiled-coil homodimer in cells (Callaghan et al., 1999) similar to 
Rabaptin5. Endosomal localization requires the interaction of PI(3)P with the FYVE domain 
on EEA1 (Stenmark et al., 1996), since mutations of conserved residues in the FYVE domain 
disrupt PI(3)P binding and localization to endosomes. In addition to the FYVE domain, EEA1 
also needs its Rab5 binding domain for endosome targeting, showing the importance of the 
dual interaction of EEA1 with Rab5 and PI(3)P for efficient membrane recruitment (Lawe et 
al., 2000). EEA1, in coordination with SNARE proteins, is essential for early endosome fu-
sion in vivo (Mills et al., 1998). It can directly interact with syntaxin6 (Simonsen et al., 1999) 
and syntaxin13 (McBride et al., 1999), two target-SNAREs that mediate homotypic early en-
dosome fusion, but the exact mechanism is still under debate. 
 
Fig. 17. Model for multivalent membrane binding by homodimeric EEA1 
EEA1 is targeted to early endosomes via the interaction with PI(3)P and Rab5-GTP. The region required 
for both dimerization and interaction with Rab5 is highlighted in magenta, while the putative IQ motif is 
highlighted in green. (Dumas et al., 2001) 
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7.4. Rabenosyn5 
Rabenosyn5 is another FYVE-domain-containing Rab5 effector that, similar to EEA1, is re-
cruited in a Rab5- and PI(3)P-dependent fashion to early endosomes. Via the interaction with 
VPS45, a member of the Sec1 family of SNARE regulators, Rabenosyn5 is supposed to 
function in docking and fusion of early endosomes (Nielsen et al., 2000). In addition, 
Rabenosyn5 was found to bind to Rab4-GTP, thus showing, similar to Rabaptin5, dual Rab5 
and Rab4 effector activity (de Renzis et al., 2002). Overexpression of Rabenosyn5 increased 
transferrin recycling from sorting endosomes but reduced the transport to recycling endo-
somes suggesting a role of Rabenosyn5 in the coordination of protein sorting with the fast 
recycling of cargo directly form sorting endosomes (de Renzis et al., 2002). Another study 
showed an interaction of Rabenosyn5 with EHD1, which regulates recycling of cargo from 
recycling endosomes to the plasma membrane. They suggest that Rabenosyn5 and EHD1 
act sequentially in the transport of proteins from sorting to recycling endosome and back to 
the plasma membrane (Naslavsky et al., 2004). Rabenosyn5 might serve as a Rab effector 
linking sorting events at early endosomes to recycling. Whether the recycling occurs directly 
from sorting endosomes or via recycling endosomes needs to be established. 
 
8. Rab conversion during endosome maturation  
A keystep in early-to-late endosome maturation is the Rab conversion, in which Rab5 pre-
sent on early endosomes is replaced by the late endosomal Rab7 (Rink et al., 2005). Rab 
conversion can be blocked by expressing dominant negative Rab5, resulting in the formation 
of hybrid endosomal compartment with markers for both early and late endosomes (Hirota et 
al., 2007). Rab5 removal from early endosomes requires the inhibition of the positive feed-
back loop described above (see Rabaptin5 chapter) as well as a GAP activation to hydrolyze 
GTP on Rab5. Del Conte-Zerial et al. (2008) described a so called cutoff switch model, 
where Rab5 activates Rab7, which in turn supresses Rab5 via interaction with effectors and 
GAPs (Del Conte-Zerial et al., 2008). The exact mechanism is starting to emerge, but there 
are still a lot of open questions. The keyplayers for the Rab conversion include the 
Mon1/Ccz1 complex (Sand1 in C. elegans) (Poteryaev et al., 2010). Mon1/Ccz1 can bind to 
Rab5 and promotes Rab7 binding by potentially displacing the GDI from Rab7 or activating 
the HOPS complex, which in yeast has been proposed to have GEF activity (Wurmser et al., 
2000). In mammalian cells, however, the components of the HOPS complex do not possess 
GEF activity towards Rab7 (Peralta et al., 2010), but the Mon1/Ccz1 complex could be the 
GEF itself as shown in yeast (Nordmann et al., 2010).  
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In addition, Mon1/Ccz1 interacts with Rabex5 and displaces it from endosomal membranes, 
thus interrupting the positive feedback loop of Rab5 activation (Poteryaev et al., 2010). To 
inactivate Rab5, a GAP has to be recruited to the endosome, which has not been identified 
yet. There have been reports about TBC-2, a Rab5-GAP in C. elegans, to be recruited to 
endosomes only when Rab7 is present (Chotard et al., 2010), but this could not be confirmed 
in mammalian cells. There the closest human homologue of TBC-2, Armus, showed GAP 
activity towards Rab7 instead of Rab5 (Frasa et al., 2010).  
 
 
Fig. 18. Rab conversion during endosome maturation 
To interrupt the positive feedback loop of Rab5 acitvation, Mon1/Ccz1 bind to Rab5 and Rabex5, caus-
ing dissociation of Rabex5 from the endosome membrane. In a next step, the Mon1/Ccz1 complex pro-
motes the recruitment and activation of Rab7, which in turn binds to the HOPS complex finally leading to 
late endosome fusion (Huotari and Helenius, 2011). 
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Aim of the thesis 
Rabaptin5 is one of the better-studied Rab effectors with a widely accepted function in early 
endosomes fusion involving the Rab5 positive feedback loop. However, Rabaptin5 is a com-
plex protein with several interactors, including Rab4, Rab5, Rabex5 and AP1, and a thorough 
analysis of the contributions of each domain has been missing. 
The aim of this work is to investigate the role of Rabaptin5 in endosomal homeostasis. We 
analyse the function of Rabaptin5 in more detail taking into account all interaction partners by 
mutagenesis of the different interaction domains or motifs and expression of the mutant pro-
teins in HeLa cells. Firstly, the contribution of the different interaction domains to Rabaptin5 
recruitment to endosomes and to endosome morphology was studied. Secondly, changes in 
Rabaptin5 localization were determined by coexpression or silencing of Rabaptin5 interac-
tors. Some of our results clearly contradict the widely cited feedback model, in which Rab5 
controls its own activity, and lead to new models of Rabaptin5 function. 
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Material and Methods 
Material 
Primary Antibodies 
Antibody Host Used for IF Supplier 
α-actin Mouse monoclonal WB 1:500’000 Millipore 
α-CHMP2B Rabbit polyclonal IF 1:200 Abcam 
α-HA Mouse monoclonal IP 5 µl Hybridoma 12CA5 
α-Rab4 Mouse monoclonal WB 1:1000 BD Transduction Laboratories 
α-Rab5 Mouse monoclonal WB 1:1000 Hybridoma CL621.3 
α-Rabaptin5 Mouse monoclonal WB 1:2000 BD Transduction Laboratories 
α-Rabaptin5 Mouse monoclonal IF 1:1000 BD Transduction Laboratories 
α-Rabaptin5  
(Rabep1) 
Rabbit polyclonal IP 5 µl Novus Biologicals 
α-Rabex5 Mouse monoclonal WB 1:1000 BD Transduction Laboratories 
α-Rabex5 Mouse monoclonal IF 1:500 BD Transduction Laboratories 
 
Secondary Antibodies 
Antibody Host Western blot IF Supplier 
α-mouse-Alexa488 goat  1:200 Molecular Probes 
α-mouse-Alexa568 goat  1:200 Molecular Probes 
α-rabbit-Alexa488 goat  1:200 Molecular Probes 
α-rabbit-Alexa568 goat  1:200 Molecular Probes 
α-mouse-HRP goat 1:4000  Sigma Immunochemicals 
α-rabbit-HRP goat 1:4000  Sigma Immunochemicals 
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Fluorochromes 
Fluorochromes Specificity IF Supplier 
Bisbenzimide H33342 Nuclei 1:1000 Hoechst 
DAPI Nuclei 1:10’000 Sigma 
DY-647-phalloidin Actin filaments 1:200 Dyomics 
EGF, biotinylated, complexed to 
Alexa488 Streptavidin 
EGF receptor 2 µg/ml Invitrogen 
Transferrin Alexa488 Tf receptor 20 µg/ml Molecular Probes 
Transferrin Alexa568 Tf receptor 20 µg/ml Molecular Probes 
 
CellLight reagents 
Reagent Specificity IF Supplier 
CellLight Early endosomes (RFP-
Rab5a) 
Early endosomes 5 µl for a 12 well Invitrogen 
CellLight Late endosomes (GFP-
Rab7a) 
Late endosomes 7 µl for a 12 well Invitrogen 
CellLight Lysosomes (GFP-
Lamp1) 
Lysosomes 6 µl for a 12 well Invitrogen 
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Methods 
Cloning 
All polymerase chain reactions (PCR) were performed using the iproof high fidelity polymer-
ase (Bio-RAD). PCR products were purified from agarose gels with the NucleoSpin Gel and 
PCR Clean-up kit (Machery Nagel) according to manufacturer’s protocol. The purified con-
structs were cut with the corresponding restriction enzymes and ligated using the T4 DNA 
ligase (Roche). The resulting constructs were transformed into E. coli UT580. 
The cDNA encoding human Rabaptin5 cloned in the pHAT vector was a gift from Marino 
Zerial (Max Planck Institute, Dresden, Germany). Wildtype Rabaptin5 and all the mutants 
were cloned into pcDNA3 (Invitrogen). To generate Rbpt5Δ5/1, Rbpt5Δ4/1 and Rbpt5Δ4 co-
dons 1-814, 136-862 and 268-862 were cloned into the vector. For Rbpt5Δ4/2, Rbpt5δ, 
Rbpt5Δ5/2 and Rbpt5ΔX, codons 140-262, 187-226, 216-318 and 547-666 respectively were 
deleted by PCR mutagenesis. Rbpt5Δ5 was produced by deleting codon 815-862 from 
Rbpt5Δ5/2. To generate Rbpt5(AAA), the codons for Asp438, Phe439 and Gly440 were substi-
tuted by alanine residues.  
The coding sequence of Rabex5 was amplified from a mouse brain cDNA library. HA-Rx5 
was constructed by the addition of the respective epitope-encoding sequences to the 5’-end 
of the coding sequence and cloned into pcDNA3.  
Human Rab4a wildtype and Rab4aS22N in pcDNA3.1 were a gift from Peter van der Sluijs 
(University of Utrecht, Utrecht, The Netherlands). Human Rab5a and Rab5aS34N in pECFP-
C1 were provided by Elizabeth Smythe (University of Sheffield, Sheffield, England, UK). 
 
MultiLabel 
For consistent coexpression of multiple proteins, we used the MultiLabel system as de-
scribed by Kriz et al. (2010). Wildtype and mutant Rbpt5 in pcDNA3 were amplified from the 
CMV promoter to the poly-A sequence with the iproof high fidelity polymerase (Bio-RAD) and 
cloned into pSI-DST2cx with T4 DNA Ligase (Roche), resulting in a donor plasmid with un-
tagged Rbpt5. Wildtype and mutant Rab4a, Rab5a, and Rabex5 were ligated into the accep-
tor vectors pSI-AAL6 or pSI-AAR6 for N-terminal fusion of a mCitrine or a mCherry tag, re-
spectively.  
Acceptor plasmids containing a pUC origin of replication were propagated in UT580 cells, 
while donor plasmids with an R6Kγ origin of replication in Pir1 cells (Invitrogen). The 
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Cre/LoxP recombination reaction was performed at 37°C for 60 minutes (New England Bio-
Labs). The unpurified Cre reaction mixture was used to transform UT580 cells by electro-
poration. 
 
Cell culture and transfection 
HeLa α and A431 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) sup-
plemented with 10% fetal calf serum (FCS), 100 units/ml penicillin, 100 units/ml streptomycin 
and 2 mM L-glutamine at 37°C in 7.5% and 5% CO2, respectively. Cells were transiently 
transfected using Fugene HD (Promega) and in some cases infected with CellLight reagents 
36 h posttransfection (see Materials) 
 
RNA Interference 
HeLa α cells were grown as described above. Cells were reverse transfected with 20 nM 
ON-TARGETplus human Rabaptin5 siRNA (3’UTR), ON-TARGETplus SMARTpool human 
Rabex5, ON-TARGETplus SMARTpool human Rab4a, ON-TARGETplus SMARTpool hu-
man Rab5a or ON-TARGETplus non-targeting control pool siRNA (Dharmacon Thermo Sci-
entific) using lipofectamine RNAiMAX (Invitrogen). Cells were used after three days. For 
some experiments, the cells were transfected with expression plasmids using Fugene HD 
(Promega) after one day and cultured for another two days. Protein silencing was tested by 
immunoblot analysis or used for crosslinking, co-immunoprecipitation or immunofluores-
cence. 
 
Crosslinking 
To test dimer formation of wildtype or mutant Rbpt5, transfected cells were incubated with 
0.1 mM membrane-permeant, non-cleavable disuccinimidyl suberate (DSS; ProteoChem) in 
PBS for 45 min at room temperature followed by quenching with 50 mM Tris-HCl, pH 7.5, for 
15 min. The cells were harvested in lysis buffer (0.5% DOC, 1% Triton, 2 mM PMSF, 1 x 
PIC) for 1 h at 4°C and subjected to immunoblot analysis.  
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Co-immunoprecipitation 
Transfected cells expressing wildtype or mutant Rbpt5 together with HA-Rabex5 were lysed 
48 h posttransfection with lysis buffer (0.5% DOC, 1% Triton, 2 mM PMSF, 1 x PIC) for 1 h at 
4°C. Post-nuclear supernatants were incubated with anti-Rbpt5 or anti-HA antibodies over-
night at 4°C, and antigen-antibody complexes were collected with protein A-Sepharose for 2 
h, washed 4 times with lysis buffer and PBS, and subjected to immunoblot analysis.  
 
SDS-PAGE and Immunoblotting 
Proteins were separated on 7.5% or 10% polyacrylamide gels and transferred to an Immobi-
lon-PSQ membrane (Millipore). After blocking with 5% nonfat dry milk in TBST for 1 h, the 
membrane was incubated for 2 h with primary antibody in TBST containing 5% BSA at room 
temperature. After a few washes, the membrane was incubated with HRP-coupled second-
ary antibody in 5% nonfat dry milk/TBST for 1h at room temperature. For protein detection 
Immobilon Western Chemiluminescent HRP Substrate (Millipore) was used and membranes 
were exposed to Kodak Biomax XAR films. 
 
In vivo recycling assay 
To assess recycling, cells were starved for 2 h in uptake medium (medium supplemented 
with 20 mM HEPES, pH7.2), incubated for 1 h at 37°C with 50 µg/ml Alexa-Fluor tagged 
transferrin in uptake medium, and washed three times with ice-cold PBS and twice with strip-
ping buffer (150 mM NaCl, 50 mM Na-Acetate, pH 3.5) to release surface transferrin. The 
cells were then quickly warmed to 37°C and internalized transferrin was chased for up to 20 
min in uptake medium supplemented with 50 mM deferoxamine mesylate salt (Sigma). To 
stop the chase, the cells were fixed with 3% paraformaldehyde in PBS, quenched with 50mM 
NH4Cl in PBS for 5 min, permeabilized with 0.1% Triton X-100 for 5 min, and stained with 1 
unit/ml Alexa-Fluor-tagged phalloidin (Dyomics) and 10 µM bisbenzimide H33342 (Hoechst) 
for 30 min. Image acquisition was done automatically with an ImageXpress Micro (Molecular 
Devices) and image analysis was performed with the CellProfiler software (Carpenter et al., 
2006).  
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EGF uptake assay 
Transfected A431 cells were grown on coverslips and washed with pre-chilled, serum-free 
growth medium supplemented with 20 mM HEPES, pH7.2. The coverslips were then incu-
bated for 30 min at 4°C in serum-free growth medium containing 1% BSA, 20 mM HEPES, 
pH7.2 and 2 µg/ml Alexa488-EGF (Invitrogen), washed three times in ice-cold PBS to re-
move excess ligand and transferred into pre-warmed growth medium. The chase was per-
formed at 37°C and 5% CO2 for 10 min, 30 min and 3 h. After each time-point, the coverslips 
were fixed with 3% paraformaldehyde and processed for immunofluorescence. 
 
Immunofluorescence 
Transfected cells were grown on coverslips for 48 h and fixed with 3% paraformaldehyde 
(PFA) for 10 min at room temperature. To quench the reaction, fixed cells were incubated for 
5 min in 50 mM NH4Cl. In some experiments, the cells were pre-permeabilized with 40 µg/ml 
digitonin (Serva) in 110 mM potassium acetate, 20 mM HEPES pH 7.2, 2 mM MgCl2 for 5 
min at 4°C to release the free cytosolic proteins prior to fixation. For the transferrin staining, 
cells were allowed to internalize 20 µg/ml Alexa-Fluor tagged transferrin in medium supple-
mented with 20mM HEPES, pH7.2 for 1h. 
Fixed cells were washed with PBS and permeabilized with 0.1% Triton X-100 (Applichem) for 
10 min. After blocking with 1% BSA in PBS for 15 min, cells were incubated for 2 h with pri-
mary antibodies in PBS containing 1% BSA, washed, and stained for 30 min with fluores-
cently tagged secondary antibodies in PBS containing 1% BSA. After a 5 min staining with 
DAPI and several washes with PBS, coverslips were mounted in Fluoromount-G (Southern 
Biotech). Used Antibodies are described in the table above. Staining patterns were analyzed 
using a Point Scanning Confocal Zeiss LSM700 upright. 
 
Endosome size measurements 
Endosome size was measured in 4 cells per condition with nicely separated endosomes. 
Pictures were analysed with Bregman segmentation of the Mosaic plugin in Fiji, provided by 
the group of Kurt Ballmer from the PSI. Background was substracted with a rolling ball radius 
of 10 pixels and cell masks were set to 0.075 to identify transfected cells. The resulting size 
values in pixel were translated into µm2 and plotted with Prism6. 
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Results 
Rabaptin5 constructs and expression levels 
To investigate the role of Rabaptin5 in endosome homeostasis, a mutation analysis was per-
formed (Fig. 19). C-terminal truncations of the well-characterized Rab5 and Rabex5 binding 
domain as well as N-terminal deletions of the two individual, putative and the entire Rab4 
binding domain were generated. In a second step also the putative N-terminal Rab5 binding 
domain was deleted. The AP1 binding site, including the tripeptide sequence DFG, was inac-
tivated by mutation to three alanine residues (AAA). A combination of different mutated sites 
lead to the following constructs (Fig. 19): 
 
Fig. 19. Illustration of the domain organization of wildtype Rabaptin5 and mutant constructs  
Coiled coil segments are shown in yellow. Coloured backgrounds highlight the segments reported to in-
teract with Rab4 (red), Rab5 (blue), Rabex5 (green), or AP1 (purple) 
 
To check the expression levels of the different constructs, endogenous Rabpatin5 was 
knocked down with a siRNA against the 3’UTR and the mutant constructs expressed in HeLa 
cells. The absence of the full-size Rabaptin5 in cells transfected with the deletion constructs 
demonstrated efficient knockdown of endogenous Rabaptin5. Western blot analysis com-
pared endogenous levels of Rabaptin5 with the mutant constructs. All constructs showed a 
2-3 fold higher expression than the endogenous protein (Fig. 20). Taking into account a 
transfection efficiency of around 10%, resulted in a 20-30 fold higher concentration of the 
transfected construct over endogenous Rabaptin5 per cell. Rbpt5(AAA) was the only con-
struct with an expression level similar to the endogenous levels of Rabaptin5, which will be 
important for the further studies (Fig. 20, lane 10). 
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Fig. 20. Expression levels of the different mutants 
Expression of Rabaptin5 constructs in Rabaptin5 wildtype silenced HeLa cells was assessed by SDS-
PAGE of extracts and immunoblotting with an anti-Rabaptin5 antibody. Expression levels were in a simi-
lar range for the majority of the constructs. Rbpt5(AAA) expressed a little less then the other constructs. 
Actin was used to ensure equal loading. Numbers on the left indicate the position of molecular mass 
markers (in kilodaltons). 
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Rabaptin5 localizes to early endosomes 
Endogenous levels of Rabaptin5 in HeLa cells were not detected by immunofluorescence 
microscopy with available antibodies. Since addition of any fluorescent protein tag to the Ra-
baptin5 sequence caused aggregation of the protein, Rabaptin5 was expressed in HeLa cells 
without tag and detected with an anti-Rabaptin5 antibody (see Material and Methods). Upon 
transient transfection, Rabaptin5 was observed in the cytosol and on membrane structures 
containing internalized fluorescent transferrin (Tf) as a marker for early endosomes (Fig. 
21A). After a brief digitonin permeabilization of the plasma membrane before fixation, only 
endosome-bound Rabaptin5 was retained (Fig. 21B). Silencing of the endogenous Rabap-
tin5 did not affect the localization of the exogenously expressed protein (Fig. 21C). In addi-
tion, the size of Tf-positive endosomes did not change upon Rabaptin5 expression (Fig. 
21E). To assess endosome size, the arithmetic mean plus its standard deviation did not rep-
resent an adequate presentation of the data, since the endosome size was spread over a 
large range better described with a box plot. A box plot depicts 50% of the values in the mid-
dle box plus minimum and maximum values on both sides (Fig. 21E). 50% of the endosomes 
in control HeLa cells had a size between 7-20 nm2, which is not affected by the moderate 
expression of Rabaptin5 wildtype (Fig. 21E). 
An increase in endosome size has been previously reported in cells treated with butyrate to 
stimulate gene expression (Deneka et al., 2003) or using the T7 RNA polymerase vaccinia 
virus expression system (Vitale et al., 1998). Indeed in butyrate-treated cells, we could re-
produce endosome enlargement by Rabaptin5 (Fig. 21D). Endosome size increased from 7-
20 nm2 to 14-75 nm2 with a maximum up to 15 µm2 (Fig. 21E). As indicated by the spindly 
appearance (Fig. 21D), the cells suffered during the butyrate treatment even leading to cell 
death and thus showing this treatment was toxic to the cells. This indicates that transfection 
of cells without butyrate treatment provides comparatively moderate protein expression. 
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Fig. 21. Rabaptin5 colocalizes with Tf-positive endosomes in transfected HeLa cells 
A) Rbpt5 transfected HeLa cells were allowed to internalize fluorescent Tf for 1h and stained with an an-
ti-Rbpt5 antibody. B) With digitonin permeabilization prior to fixation, cytosolic Rbpt5 was released. C) 
Knockdown of endogenous Rbpt5 prior to transfection did not change exogenous Rbpt5 distribution. D) 
Butyrate treatment caused endosome enlargement. E) Quantification of Tf positive endosome size. Box 
plots show median value in the centre, each box represents 50% of all values (25% quartile to 75% quar-
tile) and whiskers indicate minimal and maximal values, respectively (N=4). Bars, 10 µm. Nuclei were 
stained with DAPI (blue). 
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Rab4a enhances membrane recruitment of Rabaptin5 
For coexpression and colocalization analysis of two proteins, we used MultiLabel, a modular 
plasmid-based eukaryotic expression system (Kriz et al., 2010), that allows similar expres-
sion levels from identical promotors at a constant ratio in all transfected cells. In some cases, 
the BacMam technology was used to express a second gene. This technique is based on a 
insect virus (baculovirus), that has been modified for transgene expression in mammalian 
cells. This virus does not replicate in mammalian cells and thus no extra safety measures 
have to be taken. Cells expressing the Rabaptin5 constructs were infected with this baculovi-
rus one night before fixation. 
Expression of Rabex5 alone or together with Rbpt5 increased the average endosome size 
from 7-18 nm2 to 8-40 nm2 with maximum values up to 47 µm2 (Fig. 22A, B and Bʹ′), in 
agreement with previous reports (Mattera and Bonifacino, 2008; Zhu et al., 2007) and con-
sistent with GEF stimulated Rab5 endosome fusion. Coexpressed Rbpt5 and Rabex5 
(mCherry-tagged) colocalized on endosomes (Fig. 22B), still leaving a considerable amount 
of cytosolic Rbpt5.  
In contrast to Rabex5, expression of Rab5a or coexpression of Rbpt5/Rab5a did not change 
the overall endosome size compared to untransfected cells or Rbpt5 transfected cells (Fig. 
22C, D and Dʹ′). Coexpressed Rbpt5 and Rab5a (RFP-tagged) colocalized on endosomes 
(Fig. 22D), as did Rbpt5 and Rab4a (tagged with citrine) (Fig. 22F). Rab4a expression, both 
with and without Rbpt5, increased the range of endosome size (Fig. 22E, F and Fʹ′). The ma-
jority of endosomes still had a size of 8-20 nm2, but the maxima increased up to 14 µm2. In 
addition, Rab4a drastically reduced the cytosolic pool of Rbpt5 (Fig. 22F) compared to Rab-
ex5 and Rab5a, showing an enhanced membrane recruitment of Rbpt5, potentially via its 
Rab4-binding domain. 
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Fig. 22. Coexpression of Rab4a enhances membrane recruitment of Rbpt5 
Expression of Rx5 alone (A) or Rx5 together with Rbpt5 (B) increased the endosome size (Bʹ′), while 
Rab5a (C) or Rbpt5/Rab5a (D) did not (Dʹ′). Rab4a (E) and Rbpt5/Rab4a (F) increased the overall range 
of endosome size (Fʹ′). Only expression with Rab4a decreased the cytosolic pool of Rbpt5. Bars, 10 µm. 
Nuclei were stained with DAPI (blue). 
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Rbpt5 knockdown or Rbpt5 expression do not affect Tf recycling 
In a first attempt to investigate the role of Rabaptin5 in transferrin recycling, endogenous 
Rbpt5 was silenced (Fig. 23A, lane 5) and cells were allowed to internalize fluorescent Tf for 
1 h to fill the endosomal compartment to steady-state. Tf was chased from the cells in the 
presence of 50 µM deferoxamine and recycling was stopped every 2 min for 20 min. Rbpt5 
knockdown did neither affect the recycling rate of transferrin (Fig. 23C) nor endosome size 
(Fig. 23B) 
Secondly, Rbpt5 was expressed in HeLa cells and Tf recycling in transfected cells was com-
pared to untransfected cells. As illustrated in Fig. 23E, the distribution of fluorescent transfer-
rin in Rbpt5 expressing versus non-transfected cells is similar at 0 min recycling. After 20 min 
of recycling, essentially all the Tf was recycled back to the plasma membrane regardless of 
expressing or non-expressing cells (Fig. 23F). This result was also reflected by the recycling 
curve shown in Fig. 23D. Increased Rbpt5 expression in HeLa cells did not dramatically af-
fect the Tf recycling rate. In the first 5 min, transferrin recycling might be a little slower in 
Rbpt5 expressing cells, although not significantly different from untransfected cells. After 5 
min the two curves merge again and no difference is observable anymore, suggesting no 
involvement of wildtype Rbpt5 in the recycling pathway back to the plasma membrane. 
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Fig. 23. Rbpt5 knockdown or Rbpt5 expression do not affect Tf recycling 
A) siRNA knockdown of Rbpt5 and the three interactors Rab4a, Rab5a and Rx5. B) Quantification of en-
dosome size. C) Transferrin recycling curves for Rbpt5 siRNA and scrambled siRNA knockdown HeLa 
cells. Graph represents the mean value and standard deviation of 4 assay wells. D) Transferrin recycling 
curve for Rbpt5 expressing or untransfected HeLa cells. Graph represents the mean value and standard 
deviation of 6 assay wells. E+F) Representative pictures of D after 0 min or 20 min Tf recycling. Bars, 10 
µm. Nuclei were stained with DAPI (blue). 
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Mutation of the AP1/GGA interaction motif has no effect on Rabaptin5 
recruitment and endosome morphology 
Since AP1 is known to act at the TGN and endosomes, the interaction motif in Rbpt5 was 
mutated. To ensure proper functionality of the mutant, the dimerization ability of the protein 
was checked by in vivo crosslinking with DSS and immunoblot analysis. The efficiency of 
producing covalent dimers was the same for Rbpt5(AAA) as for wildtype Rbpt5 (Fig. 24A).  
Upon transfection of HeLa cells, Rbpt5(AAA) was observed in the cytosol and on transferrin-
positive endosomes (Fig. 24B) identical with the wildtype situation (Fig. 21A). Since 
Rbpt5(AAA) was not as highly expressed as other mutants (Fig. 20, lane 12), endogenous 
wildtype Rbpt5 might interfere and form heterodimers with Rbpt5(AAA), thus masking a po-
tential phenotype. To exclude this scenario, endogenous Rbpt5 was knocked down prior to 
transfection of the mutant. The absence of endogenous Rbpt5 had no effect on Rbpt5(AAA) 
recruitment and endosome morphology (Fig. 24C), also reflected in no change in endosome 
size compared to untransfected or Rbpt5 expressing cells (Fig. 24D). AP1 does not seem to 
be involved in recruitment to endosome. 
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Fig. 24. Mutation of the AP1 interaction motif has no effect on Rbpt5 recruitment to endosomes 
A) In vivo crosslinking with DSS to show dimerization of Rbpt5(AAA). B) Rbpt5(AAA) transfected HeLa 
cells were allowed to internalize fluorescent Tf for 1h and stained with an anti-Rbpt5 antibody. C) Knock-
down of endogenous Rbpt5 prior to transfection did not change Rbpt5(AAA) localization. D) Quantifica-
tion of endosome size. Bars, 10 µm. Nuclei were stained with DAPI (blue). 
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Rabaptin5 recruitment to endosomes requires Rabex5 
In a next step, the interaction between Rabaptin5 and Rabex5 was studied by deletion of the 
Rabex5 interaction domain in the coiled-coil CC2-1 of Rbpt5. Since it is known that Rbpt5 
homodimerizes via its coiled-coil domains, proper dimer formation was tested to ensure func-
tionality of the protein. In vivo crosslinking revealed very efficient dimerization of Rbpt5ΔX 
(Fig. 25A).  
Deletion of the Rabex5 binding domain resulted in a completely cytosolic distribution of the 
protein (Fig. 25B) and had no effect on endosome size compared to untransfected and Rbpt5 
transfected cells (Fig. 25C). That this is due to the lack of Rabex5 binding and not to an indi-
rect structural effect of the deletion was confirmed by siRNA-mediated silencing of endoge-
nous Rabex5 expression (Fig. 23A, lane 6). Rabex5 knockdown also abolished Rbpt5 
wildtype recruitment to endosomes (Fig. 25D). In addition, coexpression of Rabex5 could not 
rescue membrane recruitment of Rbpt5ΔX (Fig. 25E), indicating that the interaction with 
Rabex5 is required for membrane association. 
Interestingly, coexpression of Rab5a induced a minimal membrane recruitment (Fig. 25F), 
while Rab4a rescued the entire phenotype (Fig. 25G). Even without the Rabex5 binding do-
main, Rab4a is a potent Rbpt5 endosome recruiter apparent from the complete disappear-
ance of the cytosolic pool of the protein in Fig. 25G. 
 
 
 
 
 
 
 
 
 
Fig. 25. Rabex5 is required for Rbpt5 recruitment to endosomes 
A) Dimerization assay for Rbpt5∆X. B) Rbpt5∆X transfected HeLa cells show no endosome recruitment 
and C) no changes in endosome size. D) siRNA mediated knockdown of Rx5 caused a cytosolic distribu-
tion of Rbpt5 wildtype. E) Coexpression with Rx5 did not rescue endosome recruitment, while F) Rab5a 
partially and G) Rab4a completely could. Bars, 10 µm. Nuclei were stained with DAPI (blue). ↓ 
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Rabaptin5 recruitment to endosomes also requires Rab4a 
In the construct Rbpt5∆4, the N-terminal 285 residues including all published Rab4-binding 
sequences have been deleted. Since this mutant could not be crosslinked by DSS, the di-
merization state was tested by coimmunoprecipitation with Rabex5, the binding of which is 
critically dependent on the coiled-coil formation in the segment CC2-1 of Rbpt5. As shown by 
immunoblot analysis in Fig. 26A, Rabex5 was coimmunoprecipitated with Rbpt5∆4 and vice 
versa as efficiently as the wildtype protein, demonstrating efficient complex formation. How-
ever, Rbpt5∆4 was not recruited to endosomes, but showed a cytosolic distribution (Fig. 26B) 
and did not influence endosome size (Fig. 26C). Upon brief digitonin permeabilization prior to 
fixation, no signal was retained on cellular membranes (Fig. 26D). Transfected cells were 
identified by coexpression of mCherry, which partially localized to the nucleus and remained 
trapped during digitonin pre-permeabilization. As expected, coexpression of Rab4a could not 
rescue membrane recruitment of Rbpt5∆4 (Fig. 26E). On the other hand, coexpression of 
Rabex5 (Fig. 26F) or Rab5a (Fig. 26G) could partially induce membrane recruitment.  
To directly assess the involvement of Rab4a in endosome recruitment of Rbpt5, we analyzed 
the effects of silencing or inactivating Rab4a on the membrane recruitment of wildtype Rbpt5. 
Inactivation of Rab4a by expression of the dominant negative mutant Rab4aS22N completely 
prevented membrane binding of Rbpt5 (Fig. 27A). The same result was obtained by siRNA-
mediated silencing of Rab4a (Fig. 27B and Fig. 23A, lane 3). These and the findings from the 
previous chapter indicate that endosome recruitment of Rbpt5 is mediated by Rabex5 and 
Rab4a-GTP.  
 
 
 
 
 
 
 
Fig. 26. Deletion of the Rab4 binding domain of Rbpt5 abolishes Rbpt5 membrane recruitment.  
A) Dimerization of Rbpt5∆4 was shown by coimmunoprecipitation with Rx5 and vice versa. B) Rbpt5∆4 
transfected HeLa cells show no endosome recruitment and C) no changes in endosome size. D) With 
digitonin permeabilization prior to fixation, the cytosolic Rbpt5∆4 was released. E) Coexpression with 
Rab4a did not rescue endosome recruitment, while F) Rx5 and G) Rab5a partially could. Bars, 10 µm. 
Nuclei were stained with DAPI (blue). ↓ 
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Fig. 27. Rab4a inactivation inhibits Rbpt5 endosome recruitment 
A) No endosome recruitment of Rbpt5 with dominant negative Rab4aS22N or B) upon Rab4a siRNA si-
lencing. Bars, 10 µm. Nuclei were stained with DAPI (blue). 
 
Two distinct Rab4 interaction domains in the N-terminal portion of        
Rabaptin5 
While previous studies agreed that the N-terminal third of Rbpt5 binds to Rab4-GTP as de-
tected by yeast two-hybrid analysis (Korobko et al., 2005; Vitale et al., 1998) or GST-Rab4 
pull-down experiments (Deneka et al., 2003), they differed in the location of the interacting 
sequence(s) within this segment. Vitale et al. (1998) observed activity for residues 5–135 
(including the coiled-coil domain CC1-1), whereas Deneka et al. (2003) and Korobko et al. 
(2005) did not. Instead they observed binding to residues 140–295 (including CC1-2). Ana-
lyzing the deletion constructs Rbpt5∆4/1 lacking residues 1–135 and Rbpt5∆4/2 lacking resi-
dues 140–262 (illustrated in Fig. 19), we found both efficiently recruited to Tf-containing en-
dosomes (Fig. 28A and B), suggesting that both segments were able to bind Rab4a inde-
pendently. The two deletions, however, differed in that only Rbpt5∆4/2 caused the formation 
of giant endosomes increasing the average range of endosome size from 7-18 nm2 to 12-55 
nm2 with maximas up to 8.5 µm2. It has to be kept in mind that the deletion in Rbpt5∆4/2 also 
overlaps with the segment including residues 216–318 that had been reported to interact with 
Rab5a in a yeast two-hybrid analysis (Korobko et al., 2006). Rbpt5∆4/2 may thus reduce 
interaction with Rab5a, which could cause the different phenotype. Evidence hinting in this 
direction is that expression of Rbpt5δ, a natural splice variant lacking residues 187–226 that 
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hardly cut into the Rab5 interacting sequence (Fig. 19), did not cause endosome enlarge-
ment (Fig. 28C). 
 
Fig. 28. Dissection of the Rab4 interaction sequences in Rbpt5 
A) Rbpt5∆4/1 and B) Rbpt5∆4/2 are both independently able to bind Rab4a, C) as well as the natural 
splice variant Rbpt5δ,  but only D) Rbpt5∆4/2 induced enlarged endosomes. Bars, 10 µm. Nuclei were 
stained with DAPI (blue). 
 
Rbpt564/1 Merge
MergeTf
A
B
Tf
Rbpt564/2
C Rbpt5b Tf Merge
D
Results   
   
 
 
66 
Rabaptin5 recruitment to endosomes does not depend on Rab5a 
To verify the hypothesis that reduced Rab5a binding to Rbpt5 could cause endosome en-
largement, as mentioned above, the Rab5 binding domains were mutated. Deletion of the C-
terminal residues 815–862 containing the better characterized Rab5 binding domain did not 
affect the ability of the protein to dimerize as shown by in vivo crosslinking with DSS and 
immunoblot analysis (Fig. 29A). Expressed Rbpt5∆5/1 still recruited to Tf-containing endo-
somes (Fig. 29B) that in addition were dramatically enlarged, increasing the average range 
of endosome size from 7-18 nm2 to 17-113 nm2 with maxima up to 18 µm2 (Fig. 29F). This 
indicated that binding to Rab5a via the C-terminal domain is not essential for membrane re-
cruitment of Rbpt5 and might even be inhibitory to endosome enlargement. The giant 
Rbpt5∆5/1-decorated endosomes were still positive for Rab5a, as was shown by coexpres-
sion with RFP-Rab5a (Fig. 29C). Surprisingly, however, both Tf and Rab5a were frequently 
found inside these Rbpt5∆5/1-positive membranes. In contrast, coexpressed mCherry-
labeled Rx5 and Citrine-labeled Rab4a decorated the Rbpt5∆5/1 endosomes only externally 
(Fig. 29D and E) and decreased endosome size to the levels of the expression of Rx5 and 
Rab4a alone (Fig. 29F and Fig. 22Bʹ′/Fʹ′). Only coexpression with Rab4a reduced the cyto-
solic pool of Rbpt5∆5/1, again indicating improved recruitment to endosomes by increased 
levels of Rab4a (Fig. 29E). 
To directly assess the role of Rab5a in membrane recruitment of Rbpt5, Rab5a was inacti-
vated either by expression of the dominant negative Rab5aS34N mutant or by siRNA-
mediated silencing (Fig. 23A, lane 4). In both cases, endosome recruitment of both wildtype 
Rbpt5 and Rbpt5∆5/1 remained unaffected and both still caused the dramatic endosome 
enlargement (Fig. 30). These results argue against a role of Rab5a in membrane association 
of Rbpt5 as proposed by the feedback model. They further suggest that endosome enlarge-
ment by Rbpt5∆5/1 is not dependent on Rab5-induced endosome fusion. 
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Fig. 29. Deletion of the C-terminal Rab5-binding domain of Rbpt5 stimulates endosome enlargement 
A) Dimerization assay for Rbpt5∆5/1. Rbpt5∆5/1 recruits to B) Tf- and C) Rab5a-positive enlarged endo-
somes. Coexpressed with D) Rx5 and E) Rab4a decreases endosome size to the level of the single ex-
pression of these proteins (F), while only Rab4a improves endosome recruitment. Bars, 10 µm. Nuclei 
were stained with DAPI (blue). 
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Fig. 30. Elimination of Rab5a does not affect membrane recruitment of Rbpt5, but allows the formation of 
giant endosomes. 
A) Upon coexpression of Rab5aS34N or B) Rab5a siRNA knockdown, Rbpt5 still localizes to endosome 
and allows the formation of giant endosomes. C) The same was true for Rbpt5∆5/1 expresses together 
with Rab5aS34N or D) Rab5a siRNA knockdown. Bars, 10 µm. Nuclei were stained with DAPI (blue). 
 
Since there are reports of a second more N-terminal Rab5-binding domain on Rbpt5, also 
this binding sequence was deleted and the mutant analyzed (Fig. 19). In vivo crosslinking 
showed the same efficiency in producing covalent dimers as Rbpt5∆5/1 (Fig. 31A). Ex-
pressed Rbpt5∆5/2 also recruited to Tf-containing endosomes (Fig. 31B), which showed the 
same drastic endosome enlargement as Rbpt5Δ5/1 (Fig. 31C). Rab5a was frequently found 
inside these giant endosomes (Fig. 31D), while Rab4a only decorated the outside and in-
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creased endosome recruitment (Fig. 31E). In summary, Rbpt5Δ5/2 behaves exactly the 
same as Rbpt5Δ5/1. 
 
Fig. 31. Deletion of the N-terminal Rab5-binding domain of Rbpt5 stimulates endosome enlargement like 
Rbpt5∆5/1 
A) Dimerization assay for Rbpt5∆5/2. Rbpt5∆5/2 recruits to B) Tf-positive endosome C) highly enlarged 
in size like Rbpt5∆5/1. D) Rab5a is often found inside these structures, while E) Rab4a increases mem-
brane recruitment. Bars, 10 µm. Nuclei were stained with DAPI (blue). 
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Deletion of the individual Rab5-binding domains on Rabaptin5 induce 
early/late endosome chimeras 
As mentioned above, Rbpt5∆5/1 and Rbpt5∆5/2 showed early endosome characteristics by 
colocalizing with Tf, Rab5a and Rab4a, but surprisingly Tf and Rab5a were often found in-
side these endosomes instead of just decorating them on the outside. The latter properties 
are typically found in multivesicular bodies where parts of endosomal membranes are invagi-
nated with their associated proteins for later degradation in lysosomes. Responsible for in-
traluminal vesicle formation is the ESCRT machinery including CHMP2B/VPS2B, which is 
part of the ESCRTIII complex. The giant endosomes produced by Rbpt5Δ5/1 were indeed 
positive for the CHMP2B (Fig. 32A). The same was also observed for Rbpt5Δ5/2 (data not 
shown). Coexpressed Rab7a was found in the perinuclear region, where late endosomes are 
typically located, but also inside the Rbpt5Δ5/1-induced giant endosomes (Fig. 32B). Similar 
to the coexpression with Rab7a, Lamp1 accumulated in the perinuclear region, but also on 
the giant endosomes (Fig. 32C). Lamp1 is primarily a marker for lysosomes, but is also par-
tially found on late endosomes. The rather weak staining of Lamp1 on the giant structures 
compared to the perinuclear lysosomal staining points more to a late endosomal than lyso-
somal characteristics of the giant structures. 
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Fig. 32. Rbpt5Δ5/1-induced giant endosomes show late endosomal characteristics 
Giant endosomes induced by Rbpt5Δ5/1 colocalize with A) CHMP2B, a component of the ESCRT ma-
chinery, B) the late endosomal marker Rab7a and C) Lamp1. Bars, 10 µm. Nuclei were stained with 
DAPI (blue). 
 
To further assess the endolysosomal identity of the giant endosomes, an epidermal growth 
factor (EGF) uptake assay was performed (Fig. 33). For this experiment, A431 cells were 
used, which express high levels of EGF receptor (EGFR). The cells were allowed to bind 
fluorescently labelled EGF at 4°C at the surface and were than chased for different 
timepoints at 37°C. After 10 min of internalization, EGF typically labelled early endosomes at 
the periphery of the cell, but did not colocalize with Rbpt5Δ5/2-induced giant endosomes 
(Fig. 33A). Only after 30 min, the giant endosomes were at least partially labelled with fluo-
rescent EGF, again indicating late endosomal characteristics of these structures (Fig. 33B). 
After 3 h of uptake, EGF migrated to lysosomal structures, where it is degraded and did not 
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colocalize with the giant endosomes any more (Fig. 33C). The results from this and the pre-
vious chapters suggest a defect in the maturation process from early to late endosomes re-
sulting in giant chimeric endosomes with early and late endosomal characteristics. 
 
 
Fig. 33. Rbpt5Δ5/2-induced giant endosomes colocalize with late endosomal EGF after 30 min of uptake 
Fluorescently labelled EGF was bound on ice to the surface of A431 cells and chased for 10 min, 30 min 
or 3 h at 37°C. A) Early endosomal EGF does not colocalize with Rbpt5Δ5/2-induced giant endosomes, 
while B) late endosomal EGF does. C) After 3 h of chase, fluorescent EGF migrates to lysosomes for 
degradation and is not found on the giant endosomes any more. Bars, 10 µm. Nuclei were stained with 
DAPI (blue). 
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Transferrin recycling is affected by Rbpt5∆5/1 and Rbpt5∆5/2 
To investigate the consequences of the massive endosome enlargement induced by 
Rbpt5∆5/1 and Rbpt5∆5/2, qualitative and quantitative Tf recycling was performed. For the 
qualitative analyses, 0 and 20 min of Tf recycling were studied. After loading the cells for 1 h 
with fluorescent transferrin to steady-state, the giant endosomes of both Rbpt5∆5/1 and 
Rbpt5∆5/2 were filled with Tf (Fig. 34A and C). 20 min of recycling completely emptied un-
transfected cells, while in the expressing cells retained transferrin was easily detected exclu-
sively within giant endosomes (Fig. 34B and D). Quantitative analysis of transferrin recycling 
in Rbpt5∆5/2 expressing cells showed unaffected recycling in the first 5 min, while the recy-
cling rate moderately decreased in the following 15 min (Fig. 34E). This could be interpreted 
as a mild reduction of transferrin recycling from early endosomes. More likely though, the 
reduced recycling rate is caused by an indirect effect of transferrin uptake into intraluminal 
vesicles of the early/late endosome chimeras as shown above, thus prohibiting transferrin 
recycling back to the plasma membrane. 
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Fig. 34. Rbpt5∆5/1 and Rbpt5∆5/2 both reduce Tf recycling 
Transferrin recycling for Rbpt5∆5/1 A) at 0 min and B) 20 min recycling. C and D) show representative 
pictures for 0 min and 20 min Tf recycling for Rbpt5∆5/2. E) Quantitative anlaysis of Tf recycling in 
Rbpt5∆5/2-positive cells. Graph represents the mean value and standard deviation of 6 assay wells. 
Bars, 10 µm. Nuclei were stained with DAPI (blue). 
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Rabaptin5 missing both Rab5 binding domains only shows late endoso-
mal properties 
An obvious sequel to studying the two Rab5 binding domains on Rabaptin5 individually, was 
the analysis of the double mutant. Also Rbpt5Δ5 showed a high efficiency of producing cova-
lent dimers (Fig. 35A) and induced giant endosome similar in size to the single Rab5 binding 
domain mutants (Fig. 35B). Interestingly, the giant endosomes induced by Rbpt5Δ5 were 
negative for transferrin and Rab5 (Fig. 35C and D) indicating a loss of the early endosome 
characteristics. In contrast, staining for CHMP2B appeared on the giant endosomes as did 
coexpressed Rab7a (Fig. 35E and F), suggesting late endosomal morphology. However, 
Lamp1, which faintly stained the giant endosomes of the single mutants, did not colocalize at 
all (Fig. 35G). Rbpt5Δ5 seems to induce large endosomes with late endosome character 
excluding early endosomal and lysosomal markers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 35. Deletion of both Rab5 binding domains on Rbpt5 induces giant endosomes with late endosomal 
properties 
A) Dimerization assay for Rbpt5∆5 and B) quantitation of endosomes size. Rbpt5∆5 induced giant endo-
somes were negative for C) Tf and D) Rab5a, but colocalized with E) CHMP2B and F) Rab7a. G) The ly-
sosomal marker Lamp1 was excluded from the giant endosomes. Bars, 10 µm. Nuclei were stained with 
DAPI (blue). ↓ 
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Rabaptin5 mutant phenotypes can be observed in other cell lines 
The Rabaptin5 mutation analysis was carried out in HeLa cells. To exclude cell type specific 
effects, another cell line was analysed. A431 cells were transfected with wildtype or mutant 
Rabaptin5 and loaded with fluorescent transferrin to steady-state. Wildtype Rabaptin5 was 
observed in the cytosol and on transferrin positive early endosomes (Fig. 36A), while 
Rbpt5ΔX and Rbpt5Δ4 showed a cytosolic distribution (Fig. 36B and C). As described in 
HeLa cells, Rbpt5Δ5/1 and Rbpt5Δ5/2, where the two Rab5 binding domain were deleted 
individually, and the double deletion mutant Rbpt5Δ5 induced giant endosomes with similar 
size (Fig. 36G). Rbpt5Δ5/1 and Rbpt5Δ5/2 still contained fluorescent transferrin (Fig. 36D 
and E) showing early endosomal features, while Rbpt5Δ5 was devoid of it (Fig. 36F). 
In summary, A431 cells show the same phenotypes as HeLa cells. Individual mutants were 
additionally expressed in Cos1 cells, even belonging to a different species and also repro-
duced the same phenotypes (data not shown). This leads to the conclusion that our observa-
tions are conserved in different cell types and even species.  
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Fig. 36. A431 cells show the same phenotypes for wildtype and mutant Rbpt5 as in HeLa cells 
A) Wildtype Rbpt5 was observed in the cytosol and on early endosome, in contrast to B) Rbpt5ΔX and 
C) Rbpt5Δ4 with a primarily cytosolic distribution. While D) Rbpt5Δ5/1 and E) Rbpt5Δ5/2 induced Tf-
positive giant endosome, the huge endosome induced by F) Rbpt5Δ5 were devoid of Tf. G) Quantitation 
of endosome size. Bars, 10 µm. Nuclei were stained with DAPI (blue). 
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Discussion 
Rabaptin5 was extensively studied by several groups for more than 10 years starting with its 
discovery in 1995 (Stenmark et al., 1995). With the establishment of the positive feedback 
loop by the Zerial group, the function of Rabaptin5 was supposed to be solved and the pro-
tein moved out of the focus. With the findings in this thesis, the well-established view is chal-
lenged in serveral ways. 
Wildtype Rabaptin5 shows different effects in several studies 
Previous studies using immunofluorescence microscopy usually boosted Rabaptin5 expres-
sion by either adding sodium butyrate before analysis (Deneka et al., 2003) or using the T7 
RNA polymerase vaccinia virus expression system (Vitale et al., 1998) leading to Rabaptin5 
induced enlarged endosomes. We could reproduce the phenotype induced by butyrate (Fig. 
21D), but decided to abstain from this treatment, since endosome enlargement already visi-
ble for the wildtype could mask more prominent phenotypes of the mutant proteins or other 
interactors. Moderate expression of Rabaptin5 together with Rabex5 or Rab4a could show 
that endosome enlargement was induced by Rabex5 or Rab4a, respectively, and not by Ra-
baptin5 (Fig. 22). Massive overexpression of Rabaptin5 would have masked this effect and 
would not allow drawing correct conclusions.  
Deneka et al. (2003) also performed transferrin recycling assays upon either Rabaptin5α 
silencing or wildtype Rabaptin5α overexpression. In their case, Rbpt5 siRNA knockdown 
decreased endocytosis resulting in little transferrin in endosomes at steady-state and thus 
made it difficult to assess Tf recycling. We, however, could not observe a change in endocy-
tosis since recycling in silenced and control cells started at similar levels after loading the 
cells with transferrin to steady-state (Fig. 23C) and transferrin recycling of Rbpt5 knockdown 
cells was not affected either. Instead of analysing only a few confocal images, we used an 
automated microscope that takes into account hundreds of cells and resulting in a more 
quantitative output. 
Our transferrin recycling rate was not dramatically changed by a moderate Rabaptin5 ex-
pression (Fig. 23D). Deneka et al. (2003), however, showed that Tf recycling was delayed in 
Rabaptin5α transfected cells, where protein expression was enhanced by butyrate treatment. 
Butyrate induces higher gene expression in mammalian cells by hyperacetylating histones in 
chromatin structure (Candido et al., 1978), thereby not only influencing Rabaptin5 expression 
but also other genes. The transferrin recycling rate may thus be influenced by other upregu-
lated proteins and makes it impossible to compare these two values. 
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Our results suggest no dramatic influence of Rabaptin5 on transferrin recycling. In addition, 
the mutation of the AP1 binding site on Rabaptin5 had no influence on Rbpt5 recruitment nor 
on endosome size (Fig. 24B and D), even though AP1 was known to be involved in the for-
mation of endosome-derived vesicles in vitro (Pagano et al., 2004).  
 
Rabaptin5 recruitment to endosomes is mediated by Rabex5 and Rab4a, 
but not by Rab5a 
It has been shown that free Rabex5 (unattached to Rabaptin5) was able to recruit to endo-
somes directly via an early endosome targeting domain (Zhu et al., 2007) or by binding to 
ubiquitinated cargo on endosomes via its ubiquitin interacting motif (Mattera and Bonifacino, 
2008). This was proposed to kickstart a Rab5 activation loop by recruiting Rabaptin5/Rabex5 
complex, which in turn produces even more Rab5-GTP on early endosomes leading to a 
positive feedback loop (Zerial and McBride, 2001). One study, which supported this feedback 
model, used a Rabaptin5 mutant missing the entire C-terminal part from amino acid 547 up 
to the end of the protein. This mutant did not show endosome recruitment, which lead the 
authors to the assumption that Rab5 recruits Rabaptin5 to endosome via the C-terminal 
Rab5 binding domain on Rabaptin5 (Vitale et al., 1998).  
In agreement with the feedback model, Rabex5 expression caused the formation of large 
endosomes, which were positive for Rabaptin5 (Fig. 22B). On the other hand, deletion of the 
Rabex5 binding domain on Rabaptin5 resulted in a cytosolic distribution of the mutant with 
no endosomal recruitment as did Rabex5 siRNA knockdown for wildtype Rabaptin5 (Fig. 25B 
and D). From these results, we conclude that Rabex5 is essential for Rabaptin5 endosome 
recruitment. 
However, inconsistent with the positive feedback model were our results about the Rabap-
tin5/Rab5a interaction. We could show that Rab5a is not responsible for Rabaptin5 endo-
some recruitment, since wildtype Rabaptin5 could still recruit to endosomes in cells express-
ing dominant negative Rab5a or in Rab5a knockdown cells (Fig. 30 A/B). In addition, deletion 
of the Rab5 binding domains on Rabaptin5 did not prevent membrane recruitment (Fig. 29, 
Fig. 31, Fig. 35).  
Going back at the data from Vitale et al. (1998) with the knowledge about the binding do-
mains from nowadays, it could be observed that their mutant was not only lacking the C-
terminal Rab5 binding domain but also the Rabex5 binding domain. Most probably the lack of 
the Rabex5 binding domain in their mutant caused the defect in endosome recruitment and 
would support our view of Rabaptin5 recruitment via Rabex5 and not Rab5. 
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Surprisingly, coexpression of Rab4a with wildtype Rbpt5 enhanced membrane recruitment of 
Rabaptin5 (Fig. 22F), while inactivation of Rab4a by expression of the dominant negative 
mutant Rab4aS22N (Fig. 27A) or Rab4a siRNA-mediated silencing (Fig. 27B) completely 
prevented membrane binding of wildtype Rbpt5. This was also shown by the cytosolic distri-
bution of Rbpt5 missing the entire Rab4 binding domain (Fig. 26B). All these results strongly 
suggest that in addition to Rabex5 also Rab4a is required for endosome recruitment of Ra-
baptin5. 
This clearly contradicts the feedback model, where Rabaptin5 is recruited to endosomes via 
Rab5-GTP. Rab4, instead, was supposed to be involved in the recycling from the endosome 
to the plasma membrane. Several publications have attributed Rab4 an involvement in recy-
cling of the transferrin receptor, but its exact function remains elusive. Van der Sluijs et al. 
(1992) showed that neither Tf uptake nor Tf recycling to the plasma membrane was affected 
in CHO cells overexpressing wildtype or dominant negative Rab4. In contrast to this finding, 
it was reported that Tf recycling was strongly inhibited in HeLa cells expressing dominant 
negative Rab4 and slightly increased in cells expressing wildtype and constitutively active 
Rab4 (McCaffrey et al., 2001). Unpublished data from our lab showed no effect in Tf recy-
cling for dominant negative nor constitutive active Rab4a. Taking into account these conflict-
ing results of Rab4 involvement in endosomal recycling and the data presented in this thesis 
would suggest that Rab4 acts in an early step of Rabaptin5 recruitment to endosomes and is 
probably less important in recycling. Apparent from the presented results, we can reject the 
established positive feedback model. 
The location of the Rab4 binding domain on Rabaptin5 was also a matter of debate. Previous 
studies agreed that the N-terminal third of Rbpt5 binds to Rab4-GTP as detected by yeast 
two-hybrid analysis (Korobko et al., 2005; Vitale et al., 1998) or GST-Rab4 pull-down exper-
iments (Deneka et al., 2003), but they differed on the location of the interacting sequence(s) 
within this segment. Vitale et al. (1998) observed activity for residues 5–135 (including the 
coiled-coil domain CC1-1) in a yeast two-hybrid screen, whereas Deneka et al. (2003) 
showed binding to residues 140–295 (including CC1-2) in GST-Rab4 pull-down experiments. 
Both potential Rab4 binding sites were only analysed with biochemical assays and no in vivo 
localization studies were performed. By analyzing the deletion constructs Rbpt5∆4/1 lacking 
residues 1–135 and Rbpt5∆4/2 lacking residues 140–262 with immunofluorescence, we 
found both efficiently recruited to Tf-containing endosomes (Fig. 28A and B), suggesting that 
both segments were able to bind Rab4a independently in vivo. In addition, Rbpt5δ, a natural 
splice variant lacking residues 187–226, was expressed. According to Korobko et al. (2005), 
Rbpt5δ was not able to bind to Rab4 in a yeast two-hybrid screen and did not colocalize with 
Rab4 in BHK21 cells. We could not confirm this phenotype, since Rbpt5δ like Rbpt5∆4/2 was 
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recruited to endosomes (Fig. 28C). Our findings indicate two independent Rab4 binding do-
mains in the N-terminus of Rabaptin5 where both of them are sufficient to induce endosome 
recruitment individually and only deletion of both segments leads to dissociation from endo-
somal membranes.  
 
Interaction between Rabaptin5 and Rab5a on early endosomes inhibits 
endosome maturation 
Studying the interaction between Rabaptin5 and Rab5a did not only demonstrate Rab5-
independent endosome recruitment of Rabaptin5, but also showed a new phenotype. Dele-
tion of the individual Rab5 binding domains on Rabaptin5 induced giant endosomes positive 
for early endosomal markers like Tf, Rab4a and Rab5a (Fig. 29/Fig. 31). In addition, these 
giant endosomes showed a multivesicular appearance positive for the ESCRT component 
CHMP2B and the late endosomal markers Rab7a and Lamp1 (Fig. 32). Deletion of one of 
the two Rab5 binding domains on Rabaptin5 produced giant chimeric early/late endosomes, 
which suggests a dysregulation in endosome maturation.  
In agreement with a defect in endosome maturation is the observation that a deletion of both 
Rab5 binding domains on Rabaptin5 induces giant endosomes with only late endosomal 
properties (Fig. 35). In addition, endosome enlargement could also be shown by Rab5a inac-
tivation and subsequent wildtype Rbpt5 expression (Fig. 30). With no Rab5 interaction to 
Rabaptin5, premature late endosomes were formed.  
Our data suggest a new model (Fig. 37). Rabaptin5 is recruited to endosome by Rab4a-GTP 
and Rabex5 via two independent Rab4 and one Rabex5 binding domain on Rabaptin5. It is 
not clear, in which way Rabex5 recruits Rabaptin5 to endosomes. Lippé et al. (2001) showed 
that under physiological conditions, no free Rabex5 is present in the cell. Instead Rabex5 
forms a stable complex with one Rabaptin5 homodimer and would thus be recruited to endo-
somes as a complex (Fig. 37A). Two independent studies, however, demonstrated that free 
Rabex5 (unattached to Rabaptin5) was able to recruit to endosomes directly via an early 
endosome targeting domain (Zhu et al., 2007) or by binding to ubiquitinated cargo on endo-
somes via an ubiquitin interacting motif (Mattera and Bonifacino, 2008). This would suggest 
that membrane associated Rabex5 could recruit uncomplexed Rabaptin5 (Fig. 37B). 
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Fig. 37. Potential models of Rabaptin5 function 
Rabaptin5 is recruited to endosomes by Rab4a-GTP and Rabex5 (indicated by ↔). Membrane bound 
Rabex5 activates a local pool of Rab5, which in turn inhibits Rabaptin5 driven endosome maturation (in-
dicated by ⊥). It is not clear if Rabaptin5 is recruited to endosomes in complex with Rabex5 (A) or via 
membrane bound Rabex5, which is targeted to endosomal membranes via ubiquinated cargo (Ub) or its 
early endosome targeting domain (?) (B).  
 
Independent of Rabaptin5, membrane associated Rabex5 activates a local pool of Rab5a on 
endosomes. We speculate that Rab5a-GTP may inhibit Rabaptin5 driven endosome matura-
tion since deletion of the Rab5 binding domains on Rabaptin5 induces a premature matura-
tion process. How Rabaptin5 can promote endosome maturation is absolutely not clear. The 
current model of endosome maturation involves another Rab5 effector Mon1/Ccz1, which 
promotes Rab7 binding by potentially displacing the GDI from Rab7 (Poteryaev et al., 2010). 
So far no interaction between Mon1/Ccz1 and Rabaptin5 has been shown and it will be a 
challenge to connect Rabaptin5 driven endosome maturation with the model based on 
Mon1/Ccz1. 
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Outlook 
Our results are mainly based on immunofluorescence microscopy. In general, it would be 
beneficial to perform some biochemical experiments to show binding between the different 
proteins. Strong interactions between proteins like Rabaptin5 and Rabex5 can be detected 
by simple coimmunoprecipitation. Weaker interactions and interaction with only one form of a 
protein like the GTP-bound form of Rab proteins are more challenging to show. In vivo cross-
linking with a cleavable crosslinker like dithiobissuccinimidylpropionate (DSP) and subse-
quent coimmunoprecipitation could be one way to demonstrate interaction between different 
Rab proteins and the Rabaptin5 mutants. Another possibility is to perform dominant active 
Rab GST pull-downs with mutant Rabaptin5 lysates followed by western blot analysis. 
We could show that Rabaptin5 is recruited to endosomes by Rab4a-GTP and Rabex5. To 
decipher Rabaptin5 recruitment in the context of Rabex5 membrane association via ubiqui-
tinated cargo the ubiquitin binding site on Rabex5 will be mutated and analysed together with 
Rabaptin5. In addition, the GEF catalytic core of Rabex5 can be inactivated by a simple point 
mutation and tested, if Rabaptin5 endosome recruitment is still possible by immunofluores-
cence.  
The Rab5 binding domain in the N-terminal third of Rabaptin5 was identified in a yeast two-
hybrid screen compromising a large sequence partially overlapping with the second Rab4 
binding domain. It would be of great use to separate these two binding domains. We are cur-
rently trying to dissect the Rab5 binding into smaller pieces and will test them for Rabaptin5 
recruitment.  
The mechanism of Rabaptin5 driven endosome maturation is absolutely unclear. As a start-
ing point colocalization studies could be performed with Mon1/Ccz1, which is supposed to be 
a keyplayer in endosome maturation. In addition, coimmunoprecipitation experiments could 
show an interaction between the proteins. Most probably a Rabaptin5/Mon1 interaction is too 
simple and we suspect so far unknown interactors to be involved. To identify new Rabaptin5 
interactors, an unbiased yeast two-hybrid screen with full-length Rabaptin5 as a bait might 
identify the missing pieces in this complex process. New interactors will then be character-
ized and analysed together with Rabaptin5. 
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Abbreviations 
AAK1 Adaptor associated kinase 1 
ADP Adenosine diphosphate 
AP Adaptor protein 
ARF ADP ribosylation factor 
BAR domain Bin/Amphiphysin/Rvs domain 
CC domain Coiled-coil domain 
CCV Clathrin coated vesicle 
CHC Clathrin heavy chain 
CLC Clathrin light chain 
COPI/II Coat protein I/II 
DAPI 4’,6’-Diamidino-2-phenylindole 
DSS Disuccinimidyl suberate 
EEA1 Early endosome antigen 1 
EET domain Early endosome targeting domain 
EGF Epidermal growth factor 
EGFR EGF receptor 
EPS15 EGFR pathway substrate 15 
ER Endoplasmic reticulum 
ESCRT Endosomal sorting complex required for transport 
FCHO protein Fer/Cip4 homology domain only protein 
GAE γ-adaptin ear 
GAP GTPase activating protein 
GAPVD1 GTPase activating protein and VPS9 domain-containing protein 1 
GAT GGA and TOM 
GDF GDI displacement factor 
GDI GDP dissociation inhibitor 
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GDP Guanosine diphosphate 
GEF Guanine nucleotide exchange factor 
GFP Green fluorescent protein 
GGA Golgi-localizing, γ-adaptin ear homology domain, Arf-binding pro-
teins 
GTP Guanosine triphoshate 
GTPase GTP hydrolase 
HA Hemagglutinin 
HB Helical bundle 
HSP70 Heat shock protein 70 
HOPS Homotypic fusion and vacuole protein sorting 
IF Immunofluorescence 
ILV Intraluminal vesicle 
LAMP Lysosome associated membrane protein 
LDL Low density lipoprotein 
LDLR LDL receptor 
LMP Lysosomal membrane protein 
M6P Mannose-6-phosphate 
M6PR M6P receptor 
MBM Membrane-binding motif 
MIU Motif interacting with ubiquitin 
MVB Multivesicular body 
PCR Polymerase chain reaction 
PI Phosphoinositol 
PI(3)K Phosphoinositol-3-kinase 
PI(3)P Phosphoinositol-3-phosphate 
PI(4)P Phosphoinositol-4-phosphate 
PI(3,5)P2 Phosphoinositol-3,5-bisphosphate 
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PI(4,5)P2 Phosphoinositol-4,5-bisphosphate 
PI(3,4,5)P3 Phosphoinositol-3,4,5-triphosphate 
PR Proline-rich region 
PX Phox homology 
Rbpt5 Rabaptin5 
RFP Red fluorescent protein 
RME6 Receptor mediated endocytosis 6 
RNAi RNA interference 
siRNA Small interfering RNA 
Rx5 Rabex5 
SNARE Soluble N-ethylmaleimide-sensitive factor attachment protein  
receptor 
SNX Sorting nexin 
Tf Transferrin 
TfR Transferrin receptor 
TGN Trans Golgi Network 
VPS Vacuolar protein sorting 
VSV G protein Vesicular stomatitis virus G protein 
ZnF motif Zinc-finger motif 
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